https://curecurrent.com/trials/phase-ii-trial-of-anti-her2-treatment-in-her2-enriched-early-breast-cancer-identified-by-pam50-her2e-pam-pamilia-study-32001https://curecurrent.com/trials/cancer-nutrition-and-taste-2-32002https://curecurrent.com/trials/palbociclib-induced-neutropenia-risk-factors-and-treatment-outcome-in-metastatic-breast-cancer-patients-32003https://curecurrent.com/trials/open-label-sequential-dosing-single-ascending-dose-and-multiple-dose-safety-tolerability-and-pharmacokinetic-study-32004https://curecurrent.com/trials/behavioral-weight-loss-program-for-cancer-survivors-in-maryland-32005https://curecurrent.com/trials/dietary-habits-nutritional-knowledge-and-physical-activity-assessment-in-early-stage-breast-cancer-patients-32006https://curecurrent.com/trials/olive-oil-for-high-risk-breast-cancer-prevention-in-women-32007https://curecurrent.com/trials/palbociclib-with-cisplatin-or-carboplatin-in-advanced-solid-tumors-32008https://curecurrent.com/trials/breast-cancer-registry-for-participants-with-breast-cancer-or-characteristics-of-hereditary-breast-cancer-32009https://curecurrent.com/trials/confidence-registry-32010https://curecurrent.com/trials/effect-of-suture-material-on-postoperative-nipple-areolar-complex-widening-32011https://curecurrent.com/trials/vinorelbine-cisplatin-disulfiram-and-copper-in-ctc-emt-positive-refractory-metastatic-breast-cancer-32012https://curecurrent.com/trials/efficacy-of-denosumab-on-normal-bmd-in-women-receiving-adjuvant-aromatase-inhibitors-for-early-breast-cancer-32013https://curecurrent.com/trials/carboplatin-nab-paclitaxel-and-pembrolizumab-for-metastatic-triple-negative-breast-cancer-32014https://curecurrent.com/trials/exploring-cancer-associated-thromboembolism-prognosis-biomarkers-and-polymorphisms-32015https://curecurrent.com/trials/real-world-data-on-first-line-treatment-of-hormone-receptor-positive-her2-negative-metastatic-breast-cancer-in-brazil-32016https://curecurrent.com/trials/using-ai-to-select-women-for-supplemental-mri-in-breast-cancer-screening-32017https://curecurrent.com/trials/endocrinological-changes-due-to-pre-medications-of-chemotherapy-in-patients-with-breast-cancer-32018https://curecurrent.com/trials/capecitabine-cyclophosphamide-lapatinib-ditosylate-and-trastuzumab-in-treating-patients-with-her2-positive-metastatic-br-32019https://curecurrent.com/trials/rbx7455-before-surgery-for-the-treatment-of-operable-breast-cancer-32020https://curecurrent.com/trials/acute-post-radiation-hyperbaric-oxygen-hbo2-for-breast-cancer-patients-who-have-recently-completed-radiation-therapy-32021https://curecurrent.com/trials/evaluation-of-home-program-and-telerehabilitation-for-the-treatment-process-in-patients-with-breast-cancer-related-lymph-32022https://curecurrent.com/trials/the-rome-trial-from-histology-to-target-the-road-to-personalize-target-therapy-and-immunotherapy-32023https://curecurrent.com/trials/rural-interventions-for-screening-effectiveness-32024https://curecurrent.com/trials/a-study-to-evaluate-rucaparib-in-participants-with-solid-tumors-and-with-deleterious-mutations-in-hrr-genes-32025https://curecurrent.com/trials/early-on-treatment-transcriptional-profiling-as-predictor-of-response-in-early-stage-her2-positive-breast-cancer-32026https://curecurrent.com/trials/non-contrast-magnetic-resonance-angiography-in-deep-inferior-epigastric-perforator-flap-breast-reconstruction-planning-32027https://curecurrent.com/trials/facilitating-oncology-patient-clinician-communication-via-e-health-innovations-32028https://curecurrent.com/trials/predictors-of-response-to-neoadjuvant-docetaxel-carboplatin-chemotherapy-for-patients-with-stage-ii-and-iii-triple-negat-32029https://curecurrent.com/trials/treatment-of-insomnia-in-patients-with-breast-cancer-32030https://curecurrent.com/trials/paclitaxel-cyclophosphamide-doxorubicin-autologous-dendritic-cells-surgery-in-stage-ii-iii-breast-cancer-women-32031https://curecurrent.com/trials/randomized-controlled-trial-of-genomically-directed-therapy-in-patients-with-triple-negative-breast-cancer-32032https://curecurrent.com/trials/cyclophosphamide-and-paclitaxel-with-or-without-trastuzumab-in-stage-i-ii-breast-cancer-who-have-undergone-surgery-32033https://curecurrent.com/trials/effectiveness-of-physical-therapy-on-axillary-web-syndrome-after-breast-cancer-surgery-32034https://curecurrent.com/trials/the-patterns-of-activity-and-cognition-during-treatment-pact-study-32035https://curecurrent.com/trials/induction-of-cisplatin-nab-paclitaxel-pembrolizumab-followed-by-olaparib-pembrolizumab-maintenance-in-mtnbc-patients-32036https://curecurrent.com/trials/pilot-study-using-molecular-profiling-to-find-potential-targets-select-treatments-for-pts-with-met-br-ca-32037https://curecurrent.com/trials/18f-fluoroestradiol-fes-pet-ct-for-breast-cancer-32038https://curecurrent.com/trials/serum-and-tissue-metabolite-based-prediction-of-sentinel-lymph-node-metastasis-in-breast-cancer-32039https://curecurrent.com/trials/imx-110-in-patients-with-advanced-solid-tumors-32040https://curecurrent.com/trials/adjustable-compression-wrap-versus-compression-sleeve-to-control-breast-cancer-related-lymphedema-32041https://curecurrent.com/trials/artificial-intelligence-for-breast-cancer-screening-in-mammography-ai-stream-32042https://curecurrent.com/trials/benefits-of-morphine-gel-for-pain-reduction-in-patients-with-cancer-wounds-32043https://curecurrent.com/trials/efficacy-of-evonail-solution-in-the-prevention-of-nail-damage-induced-by-docetaxel-in-patients-with-breast-cancer-32044https://curecurrent.com/trials/comparison-of-dexamethasone-alone-vs-in-combination-with-pericardium-6-p6-electrical-stimulation-or-granisetron-in-the-p-32045https://curecurrent.com/trials/clinical-study-of-huaier-granules-in-patients-with-advanced-breast-cancer-without-visceral-metastasis-32046https://curecurrent.com/trials/is-breast-massage-necessary-to-find-sentinel-lymph-node-32047https://curecurrent.com/trials/phase-ii-study-of-dose-dense-doxurubicin-and-cyclophosphamide-ac-followed-by-paclitaxel-with-trastuzumab-in-her2-neu-amp-32048https://curecurrent.com/trials/a-study-of-a-new-drug-combination-copanlisib-and-fulvestrant-in-advanced-breast-cancer-32049https://curecurrent.com/trials/real-world-data-of-clinicopathological-characteristics-and-management-of-breast-cancer-patients-according-to-her2-status-32050https://curecurrent.com/trials/exploratory-study-of-advanced-breast-cancer-in-her2-positive-patients-with-failure-of-multi-line-therapy-treated-by-comb-32051https://curecurrent.com/trials/anlotinib-combination-with-vinorelbine-in-the-her2-advanced-breast-cancer-32052https://curecurrent.com/trials/treatment-of-dalpiciclib-combined-with-pyrotinib-for-trastuzumab-sensitive-her2-advanced-breast-cancer-dap-her-02-32053https://curecurrent.com/trials/a-study-of-pyrotinib-plus-capecitabine-in-patients-with-brain-metastases-from-her2-positive-metastatic-breast-cancer-32054https://curecurrent.com/trials/investigation-of-the-efficiency-of-pain-neuroscience-education-in-patients-with-chronic-pain-after-breast-cancer-surgery-32055https://curecurrent.com/trials/reducing-distress-and-depressive-symptoms-in-rural-women-32056https://curecurrent.com/trials/efficacy-of-point-of-service-testing-in-mbc-32057https://curecurrent.com/trials/neoadjuvant-adjuvant-chemotherapy-vaccine-adjuvant-radiation-therapy-in-p53-overexpressing-stage-iii-breast-cancer-32058https://curecurrent.com/trials/new-therapeutic-approach-in-upper-limb-lymphedema-secondary-to-breast-cancer-activity-oriented-proprioceptive-antiedema-32059https://curecurrent.com/trials/evaluation-of-the-influence-of-short-term-fasting-diet-on-chemotherapy-induced-toxicities-in-breast-cancer-patients-32060https://curecurrent.com/trials/radiation-omission-in-patients-with-her2-overexpressing-tumors-with-pathologic-complete-response-32061https://curecurrent.com/trials/caelyx-as-adjuvant-treatment-in-early-stage-luminal-b-breast-cancer-breast-cancer-32062https://curecurrent.com/trials/fujifilm-feature-comparison-reader-study-to-compare-old-vs-new-processing-32063https://curecurrent.com/trials/neoadjuvant-multi-agent-chemotherapy-or-patritumab-deruxtecan-with-or-without-endocrine-therapy-for-high-risk-hr-her2-br-32064https://curecurrent.com/trials/ft516-in-combination-with-monoclonal-antibodies-in-advanced-solid-tumors-32065https://curecurrent.com/trials/pilot-mammography-reader-study-to-assess-breast-cancer-detection-in-ffdm-plus-dbt-versus-ffdm-alone-32066https://curecurrent.com/trials/prevention-strategy-for-pre-menopausal-women-at-high-risk-for-development-of-breast-cancer-32067https://curecurrent.com/trials/study-of-kn026-monotherapy-or-combination-therapy-in-patients-with-metastatic-breast-cancer-32068https://curecurrent.com/trials/a-clinical-trial-targeting-cea-chimeric-antigen-receptor-t-car-t-for-cea-positive-advanced-malignant-solid-tumors-32069https://curecurrent.com/trials/fujifilm-dbt-plus-s-view-versus-ffdm-alone-in-the-detection-of-breast-cancer-a-pivotal-study-32070https://curecurrent.com/trials/early-detection-of-breast-cancer-32071https://curecurrent.com/trials/ft536-monotherapy-and-in-combination-with-monoclonal-antibodies-in-advanced-solid-tumors-32072https://curecurrent.com/trials/ft538-in-combination-with-monoclonal-antibodies-in-advanced-solid-tumors-32073https://curecurrent.com/trials/long-term-non-interventional-observational-study-following-treatment-with-fate-therapeutics-ft500-cellular-immunotherapy-32074https://curecurrent.com/trials/electro-acupuncture-for-the-prevention-of-taxane-induced-myalgias-and-neuropathy-32075https://curecurrent.com/trials/effect-of-wii-console-based-exercise-on-shoulder-range-of-motion-for-post-mastectomy-lymphedema-patients-32076https://curecurrent.com/trials/nutritional-intervention-induced-weight-loss-during-the-oncological-treatment-of-obesity-related-breast-cancer-32077https://curecurrent.com/trials/multi-reader-multi-case-controlled-clinical-trial-to-assess-the-fujifilm-ffdm-and-dbt-reader-training-program-32078https://curecurrent.com/trials/a-study-assessing-the-safety-and-effectiveness-of-ic2000-and-spy-fluorescence-imaging-systems-spy-phi-in-the-visualizati-32079https://curecurrent.com/trials/oncotype-dx-dcis-impact-on-radiotherapy-decision-making-32080https://curecurrent.com/trials/proton-therapy-for-early-stage-breast-cancer-32081https://curecurrent.com/trials/clinical-investigation-on-the-treatment-of-radiation-induced-dermatitis-with-fr-101-chest-dressing-32082https://curecurrent.com/trials/the-effects-of-inhaled-aromatherapy-on-chemotherapy-induced-nausea-cinv-and-vomiting-32083https://curecurrent.com/trials/pharmacokinetic-study-of-pyrotinib-and-docetaxel-in-combination-with-trastuzumab-in-patients-with-her2-metastatic-breast-32084https://curecurrent.com/trials/phase-i-ii-study-of-weekly-abraxane-and-rad001-in-women-with-locally-adv-or-metastatic-breast-ca-32085https://curecurrent.com/trials/interactive-care-plan-for-the-monitoring-of-symptoms-and-recovery-in-patients-with-stage-0-iii-breast-cancer-32086https://curecurrent.com/trials/effects-of-bariatric-surgery-on-breast-density-improvement-and-impact-on-breast-cancer-risk-in-severe-obese-patients-32087https://curecurrent.com/trials/activprosein-professional-activity-after-breast-cancer-32088https://curecurrent.com/trials/a-phase-ib-ii-study-of-shr-a1811-injection-in-breast-cancer-32089https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-metastatic-solid-tumors-32090https://curecurrent.com/trials/inetetamab-combined-with-pyrotinib-plus-oral-vinorelbine-for-the-treatment-of-her2-positive-metastatic-breast-cancer-32091https://curecurrent.com/trials/b003-in-patients-with-her2-positive-recurrent-or-metastatic-breast-cancer-32092https://curecurrent.com/trials/use-of-axillary-ultrasound-to-guide-breast-cancer-management-in-the-genomic-assay-era-32093https://curecurrent.com/trials/the-genetic-education-for-men-trial-web-based-education-vs-standard-care-32094https://curecurrent.com/trials/pyrotinib-plus-capecitabine-for-adjuvant-treatment-of-her2-positive-early-stage-breast-cancer-32095https://curecurrent.com/trials/phase-3-randomized-placebo-controlled-clinical-trial-of-donepezil-32096https://curecurrent.com/trials/feasibility-of-total-mastectomy-in-ambulatory-care-32097https://curecurrent.com/trials/genetic-and-non-genetic-breast-cancer-risk-prediction-evaluation-in-indonesian-samples-32098https://curecurrent.com/trials/a-phase-iii-randomized-trial-of-metformin-vs-placebo-in-early-stage-breast-cancer-32099https://curecurrent.com/trials/study-of-sotatercept-for-the-treatment-of-chemotherapy-induced-anemia-in-patients-with-metastatic-breast-cancer-mk-7962-32100https://curecurrent.com/trials/biomarkers-in-women-receiving-chemotherapy-celecoxib-for-stage-ii-or-stage-iii-breast-cancer-removable-by-surgery-32101https://curecurrent.com/trials/a-study-on-the-prevalence-of-clinically-useful-mutations-in-solid-tumor-characterized-by-next-generation-sequencing-meth-32102https://curecurrent.com/trials/chemokine-modulation-therapy-and-standard-chemotherapy-before-surgery-for-the-treatment-of-early-stage-triple-negative-b-32103https://curecurrent.com/trials/surgical-and-oncologic-outcomes-after-robotic-nipple-sparing-mastectomy-and-immediate-reconstruction-32104https://curecurrent.com/trials/ly3023414-and-prexasertib-in-metastatic-triple-negative-breast-cancer-32105https://curecurrent.com/trials/evaluation-of-the-role-of-immune-checkpoints-in-response-to-breast-cancer-neoadjuvant-therapy-32106https://curecurrent.com/trials/promoting-breast-cancer-screening-in-women-who-survived-childhood-cancer-32107https://curecurrent.com/trials/electrosurgical-bipolar-devices-vs-conventional-electro-cauterization-in-breast-surgery-32108https://curecurrent.com/trials/ideal-marker-for-targeted-axillary-dissection-32109https://curecurrent.com/trials/use-of-recombinant-hcg-to-prevent-breast-cancer-in-brca1-and-brca2-carriers-32110https://curecurrent.com/trials/palbociclib-rechallenge-in-hormone-receptor-positive-her2-negative-advanced-breast-cancer-palmira-32111https://curecurrent.com/trials/regional-anesthesia-and-partial-mastectomy-32112https://curecurrent.com/trials/ehealth-intervention-for-medication-adherence-in-breast-cancer-survivors-32113https://curecurrent.com/trials/nbe-002-in-patients-with-advanced-solid-tumors-32114https://curecurrent.com/trials/real-world-study-on-the-efficacy-and-safety-of-anti-her2-therapy-32115https://curecurrent.com/trials/relative-dose-intensity-of-adjuvant-chemotherapy-in-older-women-with-er-her2-breast-cancer-32116https://curecurrent.com/trials/lymphedema-treatment-registry-32117https://curecurrent.com/trials/1st-line-treatment-of-bevacizumab-taxane-vs-bevacizumab-exemestane-in-metastatic-breast-cancer-32118https://curecurrent.com/trials/addition-of-aromatase-at-the-navelbine-in-pretreated-metastatic-breast-cancer-32119https://curecurrent.com/trials/neopep-s-based-easydew-md-regen-cream-for-radiotherapy-subject-after-breast-tumor-resection-32120https://curecurrent.com/trials/tamoxifen-rad001-versus-tamoxifen-alone-in-patients-with-anti-aromatase-resistant-breast-metastatic-cancer-32121https://curecurrent.com/trials/clinical-investigation-on-the-treatment-of-radiation-induced-dermatitis-with-radiation-care-gel-32122https://curecurrent.com/trials/pattern-of-clinical-presentation-of-different-breast-disease-in-surgical-opd-at-bpkihs-32123https://curecurrent.com/trials/fast-food-fatigue-and-inflammation-32124https://curecurrent.com/trials/white-tea-for-prevention-of-chemotherapy-induced-mucositis-32125https://curecurrent.com/trials/interest-of-virtual-reality-to-prevent-cancer-patient-anxiety-before-chemotherapy-or-an-invasive-act-32126https://curecurrent.com/trials/thrive-breast-cancer-app-study-32127https://curecurrent.com/trials/facial-skin-health-tracking-feasibility-in-breast-cancer-patients-32128https://curecurrent.com/trials/a-phase-1b-2-clinical-trial-to-evaluate-the-safety-and-efficacy-of-convitvax-in-metastatic-breast-cancer-32129https://curecurrent.com/trials/diminish-chemotherapy-related-side-effects-through-patient-education-32130https://curecurrent.com/trials/study-of-urine-samples-from-women-with-newly-diagnosed-breast-cancer-enrolled-on-clinical-trial-unmc-08105-32131https://curecurrent.com/trials/pilot-study-of-bone-biopsy-and-aspirate-in-women-with-metastatic-breast-cancer-32132https://curecurrent.com/trials/exercise-in-improving-health-and-quality-of-life-in-breast-cancer-survivors-32133https://curecurrent.com/trials/effect-of-tamoxifen-or-an-aromatase-inhibitor-on-estrogen-metabolism-in-women-treated-for-newly-diagnosed-breast-cancer-32134https://curecurrent.com/trials/prospective-study-assessing-endopredict-genomic-test-impact-on-shared-decision-of-adjuvant-chemotherapy-in-patients-with-32135https://curecurrent.com/trials/fs-1502-versus-t-dm1-for-her2-positive-unresectable-locally-advanced-or-metastatic-breast-cancer-32136https://curecurrent.com/trials/fatigue-in-breast-cancer-a-behavioral-sleep-intervention-32137https://curecurrent.com/trials/pembrolizumab-and-tamoxifen-with-or-without-vorinostat-for-the-treatment-of-estrogen-receptor-positive-breast-cancer-32138https://curecurrent.com/trials/the-effect-of-cryotherapy-on-breast-cancer-patients-32139https://curecurrent.com/trials/pre-surgical-trial-of-the-combination-of-metformin-and-atorvastatin-in-newly-diagnosed-operable-breast-cancer-32140https://curecurrent.com/trials/genetic-counseling-for-menopausal-therapy-decision-making-for-women-at-increased-risk-for-breast-cancer-32141https://curecurrent.com/trials/efficacy-and-safety-of-disitamab-vedotin-plus-pyrotinib-or-naratinib-in-her2-positive-breast-cancer-patients-with-brain-32142https://curecurrent.com/trials/efficacy-and-safety-of-inetetamab-plus-pyrotiniband-and-capecitabine-in-her2-positive-metastatic-breast-cancer-patients-32143https://curecurrent.com/trials/efficacy-and-safety-of-metronomic-oral-vinorelbine-plus-anlotinib-in-her2-negative-metastatic-breast-cancer-patients-32144https://curecurrent.com/trials/weekly-paclitaxel-and-cisplatin-to-treat-hormone-receptor-positive-and-triple-negative-breast-cancer-patients-32145https://curecurrent.com/trials/oral-sm-88-in-patients-with-metastatic-hr-her2-breast-cancer-32146https://curecurrent.com/trials/exemestane-or-anastrozole-in-treating-postmenopausal-women-who-have-undergone-surgery-for-primary-breast-cancer-32147https://curecurrent.com/trials/exemestane-in-preventing-cancer-in-postmenopausal-women-at-increased-risk-of-developing-breast-cancer-32148https://curecurrent.com/trials/intrapleural-adv-tk-therapy-in-patients-with-malignant-pleural-effusion-32149https://curecurrent.com/trials/letrozole-in-breast-cancer-who-have-received-5-years-of-aromatase-inhibitor-therapy-32150https://curecurrent.com/trials/anti-anxiety-biotics-for-breast-cancer-survivors-32151https://curecurrent.com/trials/evaluation-of-blood-imaging-based-biomarkers-aromatase-inhibitor-induced-musculoskeletal-syndrome-32152https://curecurrent.com/trials/pet-imaging-as-a-biomarker-in-hormone-refractory-postmenopausal-women-32153https://curecurrent.com/trials/screening-cedm-in-intermediate-and-high-risk-patient-populations-32154https://curecurrent.com/trials/reliability-and-validity-study-of-the-evaluation-tool-for-myofascial-adhesions-in-patients-after-breast-cancer-in-turkis-32155https://curecurrent.com/trials/elastographic-and-ultrasonographic-evaluation-of-patients-with-breast-cancer-related-lymphedema-32156https://curecurrent.com/trials/investigation-of-novel-surgical-imaging-for-tumor-excision-32157https://curecurrent.com/trials/ruxolitinib-in-combination-with-trastuzumab-in-metastatic-her2-positive-breast-cancer-32158https://curecurrent.com/trials/study-of-amg-650-in-adult-participants-with-advanced-solid-tumors-32159https://curecurrent.com/trials/a-comparative-study-of-pravastatin-vs-placebo-as-primary-prevention-of-severe-subcutaneous-breast-fibrosis-in-hyper-radi-32160https://curecurrent.com/trials/evaluation-of-the-effectiveness-of-prepectoral-breast-reconstruction-32161https://curecurrent.com/trials/functional-mri-study-reconstructed-breasts-32162https://curecurrent.com/trials/effects-of-biofeedback-based-music-program-using-a-smart-device-application-on-perioperative-sleep-quality-32163https://curecurrent.com/trials/adjuvant-partial-breast-irradiation-using-stereotactic-body-radiation-therapy-32164https://curecurrent.com/trials/physician-use-of-non-english-language-skills-in-cancer-care-32165https://curecurrent.com/trials/systematic-light-exposure-for-fatigue-in-breast-cancer-patients-32166https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-margetuximab-plus-chemotherapy-in-the-treatment-of-chinese-patients-with-32167https://curecurrent.com/trials/neoadjuvant-dose-dense-for-early-her2neu-positive-breast-cancer-32168https://curecurrent.com/trials/alternative-dosing-of-exemestane-before-surgery-in-treating-postmenopausal-patients-with-stage-0-ii-estrogen-positive-br-32169https://curecurrent.com/trials/a-study-of-neoadjuvant-tchpy-pyrotinib-trastuzumab-carboplatin-and-paclitaxel-for-er-her2-breast-cancer-32170https://curecurrent.com/trials/connecting-breast-cancer-survivors-for-exercise-32171https://curecurrent.com/trials/radiation-therapy-in-treating-women-who-have-undergone-surgery-for-early-stage-invasive-breast-cancer-32172https://curecurrent.com/trials/study-of-disitamab-vedotin-and-anlotinib-in-patients-with-hr-negative-her2-low-expressing-metastatic-breast-cancer-32173https://curecurrent.com/trials/fathers-and-mothers-invested-in-lives-of-their-youth-family-study-a-pilot-intervention-32174https://curecurrent.com/trials/study-comparing-full-dose-radiotherapy-versus-reduced-dose-in-the-management-of-bone-metastasis-in-patients-with-breast-32175https://curecurrent.com/trials/experimental-study-with-pretest-posttest-groups-which-the-intervention-group-have-the-system-which-sends-reminder-notifi-32176https://curecurrent.com/trials/a-study-to-describe-the-real-world-treatment-patterns-and-associated-outcomes-in-patients-of-china-with-her2-positive-un-32177https://curecurrent.com/trials/ask-questions-asq-implementation-of-a-communication-intervention-32178https://curecurrent.com/trials/awareness-scale-related-to-physiotherapy-after-breast-cancer-a-scale-development-study-32179https://curecurrent.com/trials/a-pilot-study-to-evaluate-the-use-of-the-amma-portable-scalp-cooling-system-from-cooler-heads-32180https://curecurrent.com/trials/ipilimumab-nivolumab-and-talimogene-laherparepvec-before-surgery-in-treating-participants-with-localized-triple-negative-32181https://curecurrent.com/trials/a-study-of-shr6390-combined-with-famitinib-in-the-treatment-of-er-her2-advanced-breast-cancer-32182https://curecurrent.com/trials/management-of-severe-chemotherapy-induced-neutropenia-in-advanced-breast-cancer-32183https://curecurrent.com/trials/young-breast-cancer-survivors-study-32184https://curecurrent.com/trials/evaluation-of-ipi-549-combined-with-front-line-treatments-in-pts-with-triple-negative-breast-cancer-or-renal-cell-carcin-32185https://curecurrent.com/trials/clinical-study-to-evaluate-the-efficacy-and-safety-of-tqb2440-injection-perjeta-combined-with-trastuzumab-and-docetaxel-32186https://curecurrent.com/trials/aesthetic-effect-of-steri-strip-orientation-on-healing-and-scar-appearance-in-breast-surgery-32187https://curecurrent.com/trials/optical-spectroscopy-during-breast-cancer-surgery-and-core-needle-biopsy-32188https://curecurrent.com/trials/pet-ct-in-evaluating-response-to-chemotherapy-in-patients-with-breast-cancer-32189https://curecurrent.com/trials/following-the-use-of-gel-prosethetics-in-breast-reconstruction-32190https://curecurrent.com/trials/inst-0514c-biologic-correlative-study-trial-of-gw572016-in-her2-overexpressing-breast-cancer-patients-32191https://curecurrent.com/trials/trial-of-radiation-fractionation-schedules-for-once-a-day-accelerated-partial-breast-irradiation-32192https://curecurrent.com/trials/effect-of-coadministration-of-sotorasib-on-the-pharmacokinetics-of-rosuvastatin-in-healthy-participants-32193https://curecurrent.com/trials/a-study-of-tucatinib-vs-placebo-in-combination-with-capecitabine-trastuzumab-in-patients-with-advanced-her2-breast-cance-32194https://curecurrent.com/trials/e-health-support-program-pack-health-program-in-supporting-patient-reported-symptoms-in-newly-diagnosed-patients-with-br-32195https://curecurrent.com/trials/chidamide-everolimus-for-pik3ca-wild-type-mutant-hr-her2-advanced-breast-cancer-32196https://curecurrent.com/trials/biomarker-testing-and-treatment-patterns-among-patients-with-pik3ca-mutation-in-advanced-breast-cancer-32197https://curecurrent.com/trials/study-of-utidelone-based-neoadjuvant-treatment-on-early-high-risk-or-locally-advanced-breast-cancer-32198https://curecurrent.com/trials/ixabepilone-and-hydroxychloroquine-in-treating-patients-with-metastatic-breast-cancer-32199https://curecurrent.com/trials/treatment-decision-making-in-african-american-women-diagnosed-with-triple-negative-breast-cancer-32200https://curecurrent.com/trials/study-of-autologous-tumor-draining-lymph-node-derived-lymphocytes-as-neoadjuvant-therapy-for-her2-negative-breast-cancer-32201https://curecurrent.com/trials/study-of-autologous-tumor-draining-lymph-node-derived-lymphocytes-for-advanced-her2-negative-breast-cancer-32202https://curecurrent.com/trials/2d-speckle-tracking-echocardiography-in-chemotherapy-induced-cardiomyopathy-with-cardiovascular-risk-factors-32203https://curecurrent.com/trials/a-real-world-study-of-inetetamab-for-first-line-treatment-of-mbc-32204https://curecurrent.com/trials/effect-of-pack-health-support-program-on-patient-reported-outcomes-in-patients-with-breast-cancer-32205https://curecurrent.com/trials/a-home-based-approach-study-to-evaluate-the-efficacy-and-safety-of-alectinib-in-locally-advanced-or-metastatic-alk-posit-32206https://curecurrent.com/trials/meditation-and-cancer-pilot-feasibility-study-maeva-pilot-study-32207https://curecurrent.com/trials/tak-228-and-tak-117-followed-by-cisplatin-and-nab-paclitaxel-for-metastatic-triple-negative-breast-cancer-32208https://curecurrent.com/trials/regional-lymph-node-irradiation-for-high-risk-pn0-breast-cancer-32209https://curecurrent.com/trials/study-of-dalpiciclib-combined-with-letrozole-in-the-maintenance-treatment-of-hr-positive-and-her2-negative-metastatic-br-32210https://curecurrent.com/trials/circulating-dna-esr1-gene-mutations-analysis-32211https://curecurrent.com/trials/study-of-foretinib-in-combination-with-lapatinib-in-patients-with-metastatic-breast-cancer-32212https://curecurrent.com/trials/bone-mineral-density-in-postmenopausal-women-at-increased-risk-of-breast-cancer-and-who-are-receiving-exemestane-on-map3-32213https://curecurrent.com/trials/pilot-study-of-paclitaxel-plus-pembrolizumab-in-metastatic-her2-negative-breast-cancer-32214https://curecurrent.com/trials/ogx-011-and-docetaxel-in-treating-patients-with-metastatic-or-locally-recurrent-solid-tumors-32215https://curecurrent.com/trials/a-study-of-reolysin-for-patients-with-advanced-metastatic-breast-cancer-32216https://curecurrent.com/trials/ogx-011-and-docetaxel-in-treating-women-with-locally-advanced-or-metastatic-breast-cancer-32217https://curecurrent.com/trials/durvalumab-in-patients-with-her-2-positive-metastatic-breast-cancer-receiving-trastuzumab-32218https://curecurrent.com/trials/everolimus-in-treating-patients-with-recurrent-or-metastatic-breast-cancer-32219https://curecurrent.com/trials/a-study-of-foretinib-in-patients-with-recurrent-metastatic-breast-cancer-32220https://curecurrent.com/trials/american-breast-laser-ablation-therapy-evaluation-32221https://curecurrent.com/trials/nigerian-breast-cancer-risk-reduction-study-32222https://curecurrent.com/trials/delayed-sentinel-lymph-node-biopsy-in-ductal-cancer-in-situ-32223https://curecurrent.com/trials/genetically-engineered-cells-mage-a1-specific-t-cell-receptor-transduced-autologous-t-cells-and-atezolizumab-for-the-tre-32224https://curecurrent.com/trials/adapting-the-tumor-board-model-for-mental-illness-and-cancer-32225https://curecurrent.com/trials/discerning-the-impact-of-ctdna-detection-on-patient-decision-making-in-early-stage-breast-cancer-a-conjoint-analysis-32226https://curecurrent.com/trials/radiation-therapy-in-treating-women-with-early-stage-breast-cancer-32227https://curecurrent.com/trials/respiratory-training-and-relaxation-techniques-to-improve-adjuvant-radiation-therapy-in-dibh-in-breast-cancer-32228https://curecurrent.com/trials/immunohistochemical-immunoblot-analysis-of-nis-na-i-symporter-in-archival-frozen-tissue-sample-32229https://curecurrent.com/trials/effectiveness-of-personalized-surveillance-and-aftercare-for-breast-cancer-32230https://curecurrent.com/trials/study-of-a166-in-patients-with-relapsed-refractory-cancers-expressing-her2-antigen-or-having-amplified-her2-gene-32231https://curecurrent.com/trials/pain-control-for-breast-cancer-patients-receiving-injection-of-radioactive-tracer-32232https://curecurrent.com/trials/pegfilgrastim-and-darbepoetin-alfa-in-support-of-adjuvant-chemotherapy-for-breast-cancer-32233https://curecurrent.com/trials/the-24-hour-effects-of-remedial-exercises-with-and-without-compression-therapy-on-breast-cancer-related-lymphedema-32234https://curecurrent.com/trials/gen1029-hexabody-dr5-dr5-safety-trial-in-patients-with-malignant-solid-tumors-32235https://curecurrent.com/trials/fulvestrant-neratinib-in-breast-cancer-32236https://curecurrent.com/trials/a-study-of-shr-a1811-combined-with-capecitabine-in-treatment-of-unresectable-or-metastatic-breast-cancer-with-low-her2-e-32237https://curecurrent.com/trials/a-longitudinal-study-of-the-trajectory-of-financial-toxicity-and-its-relationship-with-symptom-burden-in-breast-cancer-p-32238https://curecurrent.com/trials/effect-of-whole-body-vibration-versus-weight-bearing-exercises-on-osteoporosis-in-breast-cancer-patients-after-chemother-32239https://curecurrent.com/trials/electrotherapy-in-the-management-of-myofascial-syndrome-32240https://curecurrent.com/trials/the-effect-of-simvastatin-on-breast-cancer-cell-growth-in-women-with-stage-i-ii-breast-cancer-32241https://curecurrent.com/trials/pd-1-il-4-inhibition-in-er-breast-cancer-32242https://curecurrent.com/trials/mhealth-usage-among-nigeria-women-diagnosed-with-breast-cancer-receiving-chemotherapy-32243https://curecurrent.com/trials/sexombc2-non-interventional-study-32244https://curecurrent.com/trials/role-of-curcumin-in-paclitaxel-induced-pn-32245https://curecurrent.com/trials/water-based-versus-land-based-exercise-for-breast-cancer-survivors-32246https://curecurrent.com/trials/comparative-effectiveness-analysis-of-granulocyte-colony-stimulating-factor-originator-products-versus-biosimilars-32247https://curecurrent.com/trials/study-to-determine-treatment-effects-of-denosumab-in-patients-with-breast-cancer-receiving-aromatase-inhibitor-therapy-32248https://curecurrent.com/trials/safety-and-efficacy-assessment-of-diagnostic-microprobe-inprobe-in-women-at-high-risk-of-breast-cancer-part-i-study-32249https://curecurrent.com/trials/predicting-chronic-pain-following-breast-surgery-32250https://curecurrent.com/trials/a-single-arm-pilot-study-to-refine-a-novel-approach-to-exercise-promotion-based-on-affect-regulation-32251https://curecurrent.com/trials/a-clinical-study-on-oncolytic-virus-injection-r130-ov-for-the-treatment-of-advanced-solid-tumors-32252https://curecurrent.com/trials/breast-radiotherapy-audio-visual-enhancement-for-sparing-the-heart-32253https://curecurrent.com/trials/a-study-of-bpi-16350-in-combination-with-fulvestrant-in-patients-with-hr-and-her2-locally-advanced-recurrent-or-metastat-32254https://curecurrent.com/trials/selective-omission-of-sentinel-lymph-node-biopsy-in-mastectomy-for-ductal-carcinoma-in-situ-identifying-eligible-candida-32255https://curecurrent.com/trials/descriptive-analysis-of-g-csf-use-in-patients-with-breast-cancer-lung-cancer-or-lymphoma-treated-32256https://curecurrent.com/trials/understanding-cardiac-events-in-breast-cancer-32257https://curecurrent.com/trials/a-study-on-the-safety-of-gen1044-duobody-cd3x5t4-in-patients-with-malignant-solid-tumors-32258https://curecurrent.com/trials/phyllodes-tumor-partial-breast-radiation-study-32259https://curecurrent.com/trials/cognitive-behavioral-stress-management-device-for-the-treatment-of-anxiety-and-depressive-symptoms-in-patients-with-stag-32260https://curecurrent.com/trials/effects-of-creatine-supplementation-in-breast-cancer-survivors-32261https://curecurrent.com/trials/cardiac-management-of-patients-with-thalassemia-minor-and-breast-cancer-32262https://curecurrent.com/trials/til-relation-to-pcr-after-neoadjuvant-therapy-in-breast-cancer-patients-32263https://curecurrent.com/trials/the-study-of-trilaciclib-combined-with-chemotherapy-on-the-neoadjuvant-therapy-of-tnbc-32264https://curecurrent.com/trials/targeting-metastatic-breast-cancers-by-alkaline-glucosodiene-molecules-via-a-metabolic-pathway-phase-i-clinical-trial-32265https://curecurrent.com/trials/pro-active-genetic-testing-in-patients-with-solid-tumors-inherit-study-32266https://curecurrent.com/trials/post-marketing-surveillance-for-the-clinical-safety-and-effectiveness-of-eribulin-mesylate-in-patients-with-inoperable-o-32267https://curecurrent.com/trials/phase-ii-study-evaluating-the-efficacy-and-safety-of-ociperlimab-in-combination-with-tislelizumab-and-chemotherapy-as-fi-32268https://curecurrent.com/trials/extended-treatment-in-metastatic-breast-cancer-with-eribulin-32269https://curecurrent.com/trials/comprehensive-genetic-assessment-risk-and-education-in-a-mammography-pilot-32270https://curecurrent.com/trials/women-in-steady-exercise-research-window-of-opportunity-for-exercise-and-tumor-biology-32271https://curecurrent.com/trials/exosome-as-the-prognostic-and-predictive-biomarker-in-ebc-patients-32272https://curecurrent.com/trials/fingolimod-in-preventing-paclitaxel-associated-neuropathy-in-patients-with-breast-cancer-32273https://curecurrent.com/trials/excisional-vacuum-assisted-breast-biopsy-32274https://curecurrent.com/trials/a-study-of-eribulin-based-regimen-versus-other-chemotherpy-in-triple-negative-metastatic-breast-cancer-eri-based-01-32275https://curecurrent.com/trials/safety-of-ultra-hypofractionated-whole-breast-irradiation-after-breast-conserving-surgery-32276https://curecurrent.com/trials/the-breast-duct-pilot-study-of-genomic-sequencing-of-exfoliated-ductal-cells-obtained-through-endoscopy-and-lavage-32277https://curecurrent.com/trials/women-on-breast-cancer-health-bel-efs-and-screen-ng-behav-ors-32278https://curecurrent.com/trials/stereotactic-radiation-and-immunotherapy-in-patients-with-advanced-triple-negative-breast-cancer-32279https://curecurrent.com/trials/mini-invasive-detection-of-residual-disease-in-breast-cancer-patients-in-remission-after-primary-chemotherapy-32280https://curecurrent.com/trials/risk-reduction-program-for-women-having-high-risk-of-breast-cancer-32281https://curecurrent.com/trials/frequency-of-occult-breast-cancer-after-prophylactic-mastectomy-among-high-penetrance-breast-cancer-gene-positives-32282https://curecurrent.com/trials/t-dxd-in-the-first-line-treatment-of-locally-advanced-or-metastatic-tnbc-lar-her2-low-patients-32283https://curecurrent.com/trials/abbreviated-breast-mri-in-cancer-detection-32284https://curecurrent.com/trials/chemokine-modulation-therapy-and-pembrolizumab-in-treating-participants-with-metastatic-triple-negative-breast-cancer-32285https://curecurrent.com/trials/trial-of-low-dose-tamoxifen-in-women-with-breast-intraepithelial-neoplasia-long-term-follow-up-32286https://curecurrent.com/trials/impact-of-omega-3-fatty-acid-supplementation-on-aromatase-in-obese-subjects-32287https://curecurrent.com/trials/study-of-kn026-in-combination-with-palbociclib-and-fulvestrant-in-patients-with-advanced-breast-cancer-32288https://curecurrent.com/trials/study-of-nuv-422-in-adults-with-recurrent-or-refractory-high-grade-gliomas-and-solid-tumors-32289https://curecurrent.com/trials/a-trial-of-eribulin-in-combination-with-hp-neoadjuvant-therapy-in-patients-with-for-her2-positive-bc-32290https://curecurrent.com/trials/incorporating-robotic-surgery-in-both-mastectomy-and-diep-flap-reconstruction-32291https://curecurrent.com/trials/electroacupuncture-for-chemotherapy-related-cognitive-impairment-32292https://curecurrent.com/trials/transcutaneous-breast-cancer-diagnosis-by-canine-odorology-32293https://curecurrent.com/trials/multimodal-pain-treatment-for-breast-cancer-surgery-a-prospective-cohort-study-32294https://curecurrent.com/trials/remotivation-process-for-improving-adherence-to-lymphedema-treatment-programs-in-patients-with-breast-cancer-related-lym-32295https://curecurrent.com/trials/successful-microsurgical-breast-reconstruction-in-minimally-invasive-mastectomy-32296https://curecurrent.com/trials/utidelone-versus-docetaxel-in-her2-negative-locally-advanced-or-metastatic-breast-cancer-32297https://curecurrent.com/trials/novel-skin-care-product-for-the-management-of-acute-radiodermatitis-32298https://curecurrent.com/trials/phase-ii-study-of-azd2281-in-patients-with-known-brca-mutation-status-or-recurrent-high-grade-ovarian-cancer-or-patients-32299https://curecurrent.com/trials/study-of-nuv-422-in-combination-with-fulvestrant-in-patients-with-hr-her2-abc-32300https://curecurrent.com/trials/combination-liposomal-irinotecan-and-pembrolizumab-for-triple-negative-breast-cancer-tnbc-with-brain-metastases-bm-32301https://curecurrent.com/trials/combination-of-serratus-anterior-and-pectoral-nerve-blocks-pecs-ii-as-main-anesthetic-method-in-breast-cancer-surgery-32302https://curecurrent.com/trials/home-based-digital-mindful-dance-program-for-breast-cancer-cases-32303https://curecurrent.com/trials/breast-cancer-risk-assessment-in-younger-women-bcan-ray-32304https://curecurrent.com/trials/seroma-reduction-and-drain-free-mastectomy-32305https://curecurrent.com/trials/evaluating-negative-pressure-wound-therapy-in-breast-conserving-surgery-32306https://curecurrent.com/trials/anti-hormonal-therapie-with-ribociclib-in-hr-positive-her2-negative-metastatic-breast-cancer-32307https://curecurrent.com/trials/a-study-to-evaluate-onm-100-an-intraoperative-fluorescence-imaging-agent-for-the-detection-of-cancer-32308https://curecurrent.com/trials/aromatherapy-methods-in-reducing-anxiety-before-breast-biopsy-32309https://curecurrent.com/trials/metformin-use-to-reduce-disparities-in-newly-diagnosed-breast-cancer-32310https://curecurrent.com/trials/characterization-of-circulating-tumor-cells-ctc-s-in-patients-with-locally-advanced-or-metastatic-stage-iv-breast-cancer-32311https://curecurrent.com/trials/self-advocacy-serious-game-in-advanced-cancer-32312https://curecurrent.com/trials/combined-estrogen-blockade-of-the-breast-with-exemestane-and-raloxifene-in-postmenopausal-women-with-a-history-of-breast-32313https://curecurrent.com/trials/neoadjuvant-therapy-with-trastuzumab-and-chemotherapy-and-the-resultant-pathologic-complete-response-observed-in-her2-po-32314https://curecurrent.com/trials/combination-chemotherapy-amifostine-and-peripheral-stem-cell-transplantation-in-treating-patients-with-stage-ii-stage-ii-32315https://curecurrent.com/trials/histological-response-rate-after-mastectomy-and-immediate-breast-reconstruction-at-the-end-of-neoadjuvant-chemotherapy-a-32316https://curecurrent.com/trials/vaccine-therapy-with-or-without-cyclophosphamide-and-doxorubicin-in-women-with-stage-iv-breast-cancer-32317https://curecurrent.com/trials/validation-of-a-tear-based-screening-assay-for-breast-cancer-32318https://curecurrent.com/trials/neulasta-controlled-trial-of-f-627-in-women-with-breast-cancer-receiving-myelotoxic-chemotherapy-32319https://curecurrent.com/trials/benign-malign-differentiation-of-axillary-lymph-nodes-the-role-of-superb-microvascular-imaging-32320https://curecurrent.com/trials/online-psychological-care-program-for-women-who-attend-a-breast-clinic-32321https://curecurrent.com/trials/study-of-tfx06-in-women-with-advanced-breast-cancer-32322https://curecurrent.com/trials/an-umbrella-trial-based-on-molecular-pathway-for-patients-with-metastatic-tnbc-in-first-line-treatment-future-trop2-32323https://curecurrent.com/trials/pilot-study-combined-molecular-breast-imaging-ultrasound-system-for-diagnostic-evaluation-of-mbi-detected-lesions-32324https://curecurrent.com/trials/radiotherapy-associated-atrial-fibrillation-32325https://curecurrent.com/trials/investigating-the-diagnostic-potential-of-tear-proteins-in-cancer-a-pilot-study-32326https://curecurrent.com/trials/effects-of-cryotherapy-on-taxane-induced-neuropathy-in-patients-with-breast-cancer-32327https://curecurrent.com/trials/safety-tolerance-pk-and-anti-tumour-activity-of-azd1775-monotherapy-in-patients-with-advanced-solid-tumours-32328https://curecurrent.com/trials/tpst-1120-as-monotherapy-and-in-combination-with-nivolumab-in-subjects-with-advanced-cancers-32329https://curecurrent.com/trials/assessment-of-periodic-screening-of-women-with-denser-breast-using-wbus-and-dbt-32330https://curecurrent.com/trials/tamoxifen-citrate-in-treating-patients-with-metastatic-or-recurrent-breast-cancer-32331https://curecurrent.com/trials/randomized-study-comparing-cmf-and-goserelin-tamoxifen-in-premenopausal-receptor-positive-patients-32332https://curecurrent.com/trials/early-surgery-or-standard-palliative-therapy-in-treating-patients-with-stage-iv-breast-cancer-32333https://curecurrent.com/trials/next-generation-sequencing-based-germline-and-somatic-genetic-testing-in-triple-negative-breast-cancer-32334https://curecurrent.com/trials/histology-vabb-histology-post-surgery-pilot-project-betty-trial-32335https://curecurrent.com/trials/phase-iii-randomized-double-blind-trial-low-dose-tamoxifen-versus-placebo-in-hormone-replacement-therapy-hrt-users-32336https://curecurrent.com/trials/metronomic-oral-chemotherapy-with-cyclophosphamide-capecitabine-and-vinorelbine-in-metastatic-breast-cancer-patients-32337https://curecurrent.com/trials/imipramine-on-er-ve-and-triple-negative-breast-cancer-32338https://curecurrent.com/trials/patients-preferences-for-adjuvant-endocrine-therapy-in-early-breast-cancer-32339https://curecurrent.com/trials/predicting-effective-adaptation-to-breast-cancer-to-help-women-to-bounce-back-32340https://curecurrent.com/trials/the-effect-of-therapeutic-mammoplasty-on-the-start-of-adjuvant-chemotherapy-32341https://curecurrent.com/trials/phase-ii-study-of-metformin-for-reduction-of-obesity-associated-breast-cancer-risk-32342https://curecurrent.com/trials/extracorporeal-shock-wave-and-a-tailored-exercise-program-on-axillary-web-syndrome-32343https://curecurrent.com/trials/cr1447-in-endocrine-responsive-her2neg-and-tn-arpos-breast-cancer-32344https://curecurrent.com/trials/a-cohort-study-of-musculoskeletal-health-in-patients-with-breast-cancer-during-aromatase-inhibitors-therapy-32345https://curecurrent.com/trials/different-targeted-antibody-drug-conjugates-for-her2-ultra-low-or-no-expression-advanced-breast-cancer-galaxy-32346https://curecurrent.com/trials/activity-program-during-aromatase-inhibitor-therapy-32347https://curecurrent.com/trials/ec-thp-versus-tcbhp-in-her2-positive-lymph-node-positive-early-breast-cancer-32348https://curecurrent.com/trials/survival-impact-of-internal-mammary-or-supraclavicular-lymphadenectomy-32349https://curecurrent.com/trials/unnecessary-mastectomy-due-to-false-size-prediction-by-preoperative-imaging-studies-in-breast-cancer-32350https://curecurrent.com/trials/comparison-of-nipple-areolar-complex-sensation-according-to-incision-types-in-nipple-sparing-mastectomy-32351https://curecurrent.com/trials/realistic-evaluation-of-a-job-retention-program-after-breast-cancer-32352https://curecurrent.com/trials/smart-optical-and-ultrasound-diagnostic-of-breast-cancer-32353https://curecurrent.com/trials/managing-breast-cancer-treatment-dyad-s-perspectives-on-treatment-decision-financial-and-family-burden-32354https://curecurrent.com/trials/a-window-of-opportunity-study-of-u3-1402-a-her3-targeting-antibody-drug-conjugate-in-operable-breast-cancer-according-to-32355https://curecurrent.com/trials/predictive-biomarkers-of-response-to-checkpoint-inhibitors-in-triple-negative-breast-cancer-a-multiomics-platform-32356https://curecurrent.com/trials/a-study-of-single-agent-eribulin-mesylate-as-first-line-therapy-for-locally-recurrent-or-metastatic-human-epidermal-grow-32357https://curecurrent.com/trials/eribulin-with-trastuzumab-as-first-line-therapy-for-locally-recurrent-or-metastatic-her2-positive-breast-cancer-32358https://curecurrent.com/trials/the-effect-of-preoperative-education-on-postoperative-healing-quality-in-patients-with-mastectomy-32359https://curecurrent.com/trials/disitamab-vedotin-rc48-in-hormone-receptor-positive-her2-low-metastatic-breast-cancer-the-rosy-trial-32360https://curecurrent.com/trials/pain-control-in-patients-with-recurrent-or-metastatic-breast-or-prostate-cancer-32361https://curecurrent.com/trials/autologous-t-cells-expressing-met-scfv-car-rna-cart-cmet-32362https://curecurrent.com/trials/safe-de-escalation-of-chemotherapy-for-stage-1-breast-cancer-32363https://curecurrent.com/trials/phase-2-study-of-imprime-pgg-and-pembrolizumab-in-patients-with-hr-her2-metastatic-breast-cancer-mbca-32364https://curecurrent.com/trials/gemcitabine-hydrochloride-and-genistein-in-treating-women-with-stage-iv-breast-cancer-32365https://curecurrent.com/trials/acupuncture-to-reduce-chemotherapy-induced-peripheral-neuropathy-severity-during-neoadjuvant-or-adjuvant-weekly-paclitax-32366https://curecurrent.com/trials/cmet-car-rna-t-cells-targeting-breast-cancer-32367https://curecurrent.com/trials/efficacy-of-multi-waved-locked-system-laser-versus-cold-compression-therapy-on-breast-cancer-related-lymphoedema-32368https://curecurrent.com/trials/tucatinib-with-chemotherapy-and-trastuzumab-in-advanced-her-2-neu-overexpressing-previously-treated-breast-cancer-32369https://curecurrent.com/trials/clinical-data-collection-in-breast-tomosynthesis-cobris-32370https://curecurrent.com/trials/muscle-energy-technique-and-mulligan-s-mobilization-in-breast-cancer-surgery-patients-32371https://curecurrent.com/trials/a-study-comparing-eribulin-mesylate-and-ixabepilone-in-causing-or-exacerbating-neuropathy-in-participants-with-advanced-32372https://curecurrent.com/trials/eribulin-in-combination-with-capecitabine-for-adjuvant-treatment-in-estrogen-receptor-positive-early-stage-breast-cancer-32373https://curecurrent.com/trials/axillary-surgery-de-escalation-after-neoadjuvant-therapy-using-dedicate-breast-pet-32374https://curecurrent.com/trials/evaluation-of-breast-cancer-recurrence-rates-following-surgery-in-women-with-ductal-carcinoma-in-situ-32375https://curecurrent.com/trials/evaluating-xihuang-pill-to-improve-the-efficacy-of-neoadjuvant-chemotherapy-for-breast-cancer-32376https://curecurrent.com/trials/impact-of-immuno-oncologic-agent-on-neoadjuvant-chemotherapy-in-triple-negative-breast-cancer-32377https://curecurrent.com/trials/chemotherapy-in-treating-women-with-previously-treated-metastatic-breast-cancer-32378https://curecurrent.com/trials/effect-of-low-vs-moderate-intensity-endurance-exercise-on-physical-functioning-among-breast-cancer-survivors-32379https://curecurrent.com/trials/follow-up-protocol-for-patients-with-cancer-aids-skin-disease-32380https://curecurrent.com/trials/quality-of-life-in-female-breast-cancer-survivors-and-their-spouse-partner-or-acquaintance-32381https://curecurrent.com/trials/a-study-of-the-pd-l1xcd27-bispecific-antibody-cdx-527-in-patients-with-advanced-malignancies-32382https://curecurrent.com/trials/autologous-humnc2-car44-or-humnc2-car22-t-cells-for-breast-cancer-targeting-cleaved-form-of-muc1-muc1-32383https://curecurrent.com/trials/study-of-symptoms-caused-by-cancer-and-cancer-therapy-in-patients-with-invasive-breast-lung-prostate-or-colorectal-cance-32384https://curecurrent.com/trials/neratinib-in-treating-older-patients-with-stage-iv-her2-positive-breast-cancer-32385https://curecurrent.com/trials/an-open-label-multicenter-phase-1-2-study-of-poly-adp-ribose-polymerase-parp-inhibitor-e7449-as-single-agent-in-subjects-32386https://curecurrent.com/trials/breast-localization-rfid-tags-vs-wire-localization-32387https://curecurrent.com/trials/marimastat-or-no-further-therapy-in-treating-women-with-metastatic-breast-cancer-that-is-responding-or-stable-following-32388https://curecurrent.com/trials/quality-of-life-in-postmenopausal-women-who-are-receiving-either-exemestane-or-anastrozole-with-or-without-celecoxib-for-32389https://curecurrent.com/trials/identification-of-genes-associated-with-cancer-in-patients-and-siblings-who-have-cancer-32390https://curecurrent.com/trials/hormone-replacement-therapy-for-hot-flashes-and-or-vaginal-symptoms-in-postmenopausal-women-receiving-tamoxifen-for-brea-32391https://curecurrent.com/trials/limited-adjuvant-endocrine-therapy-for-low-risk-breast-cancer-32392https://curecurrent.com/trials/combination-chemotherapy-in-treating-women-with-breast-cancer-32393https://curecurrent.com/trials/breast-cancer-detection-in-breast-surgical-specimens-with-the-histolog-scanner-slide-free-confocal-microscope-32394https://curecurrent.com/trials/physician-initiated-stop-smoking-program-for-patients-receiving-treatment-for-early-stage-cancer-32395https://curecurrent.com/trials/combination-chemotherapy-in-treating-women-with-stage-ii-or-stage-iiia-breast-cancer-that-has-spread-to-the-lymph-nodes-32396https://curecurrent.com/trials/phase-i-study-of-zn-c3-and-bevacizumab-pembrolizumab-in-metastatic-ccne1-amplified-and-tp53-mutant-solid-tumors-32397https://curecurrent.com/trials/paclitaxel-with-or-without-bevacizumab-in-treating-patients-with-locally-recurrent-or-metastatic-breast-cancer-32398https://curecurrent.com/trials/homologous-recombination-repair-pathway-gene-mutation-spectrum-in-chinese-breast-cancer-patients-32399https://curecurrent.com/trials/evaluation-of-ultrasonic-scissors-and-diathermy-for-axillary-clearance-in-breast-cancer-patients-32400https://curecurrent.com/trials/dp303c-in-patients-with-her2-positive-advanced-breast-cancer-32401https://curecurrent.com/trials/study-of-breast-cancer-prevention-by-letrozole-in-high-risk-women-32402https://curecurrent.com/trials/the-effect-of-early-rehabilitation-after-breast-cancer-surgery-on-physical-and-psychosocial-functions-32403https://curecurrent.com/trials/impact-of-pre-operative-web-based-breast-cancer-information-on-the-quality-of-patient-decision-making-32404https://curecurrent.com/trials/narrative-visualization-for-breast-cancer-survivors-physical-activity-32405https://curecurrent.com/trials/4d-ct-scan-versus-3d-ct-scan-concerning-cardiac-dosimetry-assesment-for-left-sided-breast-cancers-radiotherapy-32406https://curecurrent.com/trials/clinical-outcomes-for-offering-genetic-testing-in-a-tiered-approach-32407https://curecurrent.com/trials/pink-warrior-2-teleconference-based-gaming-support-32408https://curecurrent.com/trials/study-of-oncr-177-alone-and-in-combination-with-pd-1-blockade-in-adult-subjects-with-advanced-and-or-refractory-cutaneou-32409https://curecurrent.com/trials/a-study-of-kn046-in-subjects-with-locally-advanced-or-metastatic-triple-negative-breast-cancer-32410https://curecurrent.com/trials/dexmedetomedine-and-ketamine-in-erector-spinae-block-for-postoperative-analgesia-following-mastectomy-32411https://curecurrent.com/trials/acute-effects-of-chemotherapy-administration-on-skeletal-muscle-of-breast-cancer-patients-the-protect-06-study-32412https://curecurrent.com/trials/nbp-in-women-with-metastatic-breast-cancer-to-prevent-nab-paclitaxel-induced-toxic-neuropathy-32413https://curecurrent.com/trials/a-phase-ib-dose-escalation-study-of-the-combination-of-lee011-with-letrozole-and-dose-expansion-of-lee011-with-hormonal-32414https://curecurrent.com/trials/the-clinical-value-of-an-artificial-intelligence-system-using-abbreviated-protocol-of-breast-mri-facilitates-classificat-32415https://curecurrent.com/trials/drug-resistance-inhibition-in-treating-women-with-recurrent-or-metastatic-breast-cancer-32416https://curecurrent.com/trials/strategy-therapy-on-cancer-therapy-related-cardiac-dysfunction-32417https://curecurrent.com/trials/imm2520-a-pd-l1-and-cd47-bispecific-antibody-in-patients-with-advanced-solid-tumors-32418https://curecurrent.com/trials/a-study-of-chidamide-plus-endocrine-in-maintenance-treatment-of-hr-her2-breast-cancer-after-first-line-chemotherapy-32419https://curecurrent.com/trials/neo-adjuvant-abemaciclib-with-fulvestrant-in-patients-with-er-pr-her-negative-breast-cancer-32420https://curecurrent.com/trials/short-term-sintilimab-in-combination-with-taxane-and-carboplatin-for-neoadjuvant-therapy-in-triple-negative-breast-cance-32421https://curecurrent.com/trials/evaluation-of-neonavia-biopsy-system-in-axillary-lymph-nodes-32422https://curecurrent.com/trials/the-preq-20-trial-a-prospective-cohort-study-of-patients-undergoing-prepectoral-breast-reconstruction-32423https://curecurrent.com/trials/paravertebral-block-pvc-versus-pectoral-nerve-block-pec-32424https://curecurrent.com/trials/stellate-ganglion-block-sgb-for-women-for-breast-cancer-32425https://curecurrent.com/trials/allogeneic-stem-cell-transplant-after-atg-high-dose-melphalan-and-fludarabine-for-patients-with-breast-cancer-32426https://curecurrent.com/trials/discovering-factors-in-metastatic-breast-cancer-patients-clinical-trial-experiences-32427https://curecurrent.com/trials/harvest-of-ctcs-from-mbc-patients-using-the-parsortix-pc1-system-32428https://curecurrent.com/trials/smartphone-technology-to-alleviate-malignant-pain-stamp-32429https://curecurrent.com/trials/a-randomized-controlled-open-label-clinical-trial-of-adjuvant-intensive-therapy-for-hr-her2-snf4-early-breast-cancer-32430https://curecurrent.com/trials/a-clinical-study-on-oncolytic-virus-injection-r130-for-the-treatment-of-relapsed-refractory-advanced-solid-tumors-32431https://curecurrent.com/trials/non-surgical-treatment-microwave-ablation-of-breast-cancer-32432https://curecurrent.com/trials/pilot-study-to-evaluate-the-prevention-and-safety-of-doxorubicin-induced-cardiomyopathy-using-extracorporeal-shock-waves-32433https://curecurrent.com/trials/preoperative-treatment-of-hr-her2-breast-cancer-with-pirotinib-trastuzumab-and-ai-research-32434https://curecurrent.com/trials/comparison-trial-of-open-tip-pulsed-needle-biopsy-and-conventional-core-biopsy-in-axillary-lymph-nodes-32435https://curecurrent.com/trials/tavo-and-pembrolizumab-with-or-without-chemotherapy-in-patients-with-inoperable-locally-advanced-or-metastatic-tnbc-32436https://curecurrent.com/trials/early-detection-of-cmp-in-patients-with-breast-cancer-using-cardiac-magnetic-resonance-32437https://curecurrent.com/trials/screening-of-genetic-susceptibility-genes-for-breast-cancer-patients-in-chinese-communities-32438https://curecurrent.com/trials/the-effect-of-cancer-education-on-women-s-awareness-levels-and-their-behaviors-on-screenings-32439https://curecurrent.com/trials/yoga-based-rehabilitation-program-in-reducing-physical-and-emotional-side-effects-in-patients-with-cancer-32440https://curecurrent.com/trials/vinorelbine-versus-gemcitabine-plus-vinorelbine-in-metastatic-breast-cancer-patients-32441https://curecurrent.com/trials/evaluation-of-the-bexa-breast-examination-bbe-32442https://curecurrent.com/trials/desflurane-and-postoperative-sleep-quality-in-patients-undergoing-elective-breast-surgery-32443https://curecurrent.com/trials/rehabilitation-on-equal-terms-the-remig-study-32444https://curecurrent.com/trials/different-volumes-of-erector-spinae-plane-block-for-breast-surgery-32445https://curecurrent.com/trials/pyrotinib-after-trastuzumab-based-adjuvant-therapy-in-patients-with-her2-positive-breast-cancer-32446https://curecurrent.com/trials/intraoperative-use-of-an-optical-coherence-tomography-oct-imaging-system-to-guide-additional-margin-cavity-shaves-in-bre-32447https://curecurrent.com/trials/experiment-on-the-use-of-innovative-computer-vision-technologies-for-analysis-of-medical-images-in-the-moscow-healthcare-32448https://curecurrent.com/trials/prospective-study-of-particle-radiotherapy-for-breast-cancer-with-different-arm-position-32449https://curecurrent.com/trials/effect-of-platinum-based-versus-non-platinum-based-neoadjuvant-chemotherapy-in-triple-negative-breast-cancer-32450https://curecurrent.com/trials/eribulin-as-a-second-line-treatment-in-triple-negative-advanced-breast-cancer-32451https://curecurrent.com/trials/role-of-irisin-fndc5-rs3480-single-nucleotide-polymorphism-in-breast-cancer-32452https://curecurrent.com/trials/paclitaxel-albumin-stabilized-nanoparticle-formulation-in-treating-patients-with-advanced-or-refractory-solid-tumors-32453https://curecurrent.com/trials/comparison-of-at-pr-training-to-improve-functional-ability-after-breast-cancer-surgery-32454https://curecurrent.com/trials/the-effect-of-breast-cancer-screening-training-32455https://curecurrent.com/trials/study-evaluating-flexitouch-plus-with-connectivity-on-compliance-in-30-patients-with-breast-cancer-related-lymphedema-32456https://curecurrent.com/trials/autophagy-activation-for-the-alleviation-of-cardiomyopathy-symptoms-after-anthracycline-treatment-atacar-trial-32457https://curecurrent.com/trials/exploratory-study-of-sunitinib-malate-as-a-component-of-neoadjuvant-therapy-for-breast-cancer-32458https://curecurrent.com/trials/biomarkers-in-patients-with-metastatic-breast-cancer-32459https://curecurrent.com/trials/kinesiology-taping-technique-in-post-mastectomy-breast-cancer-related-lymphedema-32460https://curecurrent.com/trials/study-of-moderate-dose-omega-3-fatty-acid-supplement-in-premenopausal-women-at-high-risk-for-breast-cancer-32461https://curecurrent.com/trials/clear-b-cancer-landscape-early-adjuvant-retrospective-registry-breast-cancer-32462https://curecurrent.com/trials/hong-kong-breast-cancer-study-32463https://curecurrent.com/trials/a-multicenter-randomized-open-phase-iii-trial-of-ddec-thpvs-evaluating-the-efficacy-and-safety-of-tchp-neoadjuvant-thera-32464https://curecurrent.com/trials/study-of-camrelizumab-plus-apatinib-and-chemotherapy-as-neoadjuvant-therapy-in-participants-with-triple-negative-breast-32465https://curecurrent.com/trials/study-of-single-dose-cyclophosphamide-pembrolizumab-in-patients-with-metastatic-triple-negative-breast-cancer-32466https://curecurrent.com/trials/study-in-participants-with-early-stage-or-locally-advanced-human-epidermal-growth-factor-receptor-her-2-positive-breast-32467https://curecurrent.com/trials/a-study-in-patients-with-advanced-breast-cancer-32468https://curecurrent.com/trials/protocol-to-examine-methylation-of-tumor-suppression-genes-in-women-at-high-risk-of-developing-breast-cancer-32469https://curecurrent.com/trials/molecular-analysis-of-the-sloane-project-32470https://curecurrent.com/trials/mri-in-detecting-heart-damage-in-patients-with-cancer-receiving-chemotherapy-with-exercise-capacity-addendum-32471https://curecurrent.com/trials/wide-field-optical-coherence-tomography-imaging-of-excised-breast-tissue-32472https://curecurrent.com/trials/anti-hormone-therapy-with-anastrazole-and-fulvestrant-before-surgery-to-treat-postmenopausal-women-with-breast-cancer-32473https://curecurrent.com/trials/implantable-microdevice-for-tnbc-pilot-study-32474https://curecurrent.com/trials/training-data-collection-ai-development-32475https://curecurrent.com/trials/combining-interventions-of-fertility-preservation-to-mitigate-fertility-loss-after-breast-cancer-32476https://curecurrent.com/trials/comparative-evaluation-of-efficacy-and-safety-of-toremifene-tamoxifen-and-aromatase-inhibitor-plus-ovarian-function-supp-32477https://curecurrent.com/trials/depo-trigger-trial-gnrh-agonist-depot-trigger-for-final-oocyte-maturation-32478https://curecurrent.com/trials/targeting-triple-negative-breast-cancer-metabolism-with-a-combination-of-chemoimmunotherapy-and-a-fasting-like-approach-32479https://curecurrent.com/trials/the-study-of-vidicizumab-combined-with-tirelizumab-in-the-treatment-of-breast-cancer-with-low-her2-expression-32480https://curecurrent.com/trials/study-of-real-world-evidence-in-patients-treated-with-palbociclib-during-a-2-5-years-follow-up-period-32481https://curecurrent.com/trials/prone-breath-hold-technique-to-decrease-cardiac-and-pulmonary-doses-in-women-receiving-left-breast-radiotherapy-32482https://curecurrent.com/trials/phase-ii-open-label-trial-of-tarceva-in-women-with-metastatic-hormone-and-her2-negative-breast-cancer-32483https://curecurrent.com/trials/promoting-physical-activity-in-breast-cancer-survivors-on-aromatase-inhibitors-32484https://curecurrent.com/trials/design-of-chatbot-persona-for-breast-cancer-screening-outreach-among-black-women-32485https://curecurrent.com/trials/a-study-of-14c-gb491-in-male-healthy-subjects-32486https://curecurrent.com/trials/cdk4-6-inhibitors-in-patients-with-hormone-receptor-positive-advanced-breast-cancer-32487https://curecurrent.com/trials/feasibility-and-metabolic-effects-of-a-5-2-fasting-intervention-in-women-with-breast-cancer-during-radiotherapy-32488https://curecurrent.com/trials/efficacy-and-safety-of-ly01005-in-patients-with-breast-cancer-compared-to-zoladex-32489https://curecurrent.com/trials/a-clinical-study-on-oncolytic-virus-injection-r130-for-the-treatment-of-advanced-solid-tumors-32490https://curecurrent.com/trials/frequency-domain-optical-imaging-32491https://curecurrent.com/trials/shared-decision-making-on-care-pathways-and-cams-a-pilot-study-32492https://curecurrent.com/trials/a-study-with-pembrolizumab-in-combination-with-dual-anti-her2-blockade-with-trastuzumab-and-pertuzumab-in-early-breast-c-32493https://curecurrent.com/trials/artificial-intelligence-for-automated-diagnosis-of-breast-cancer-32494https://curecurrent.com/trials/evaluation-of-pharmacodynamic-effects-of-it-pil12-ep-in-patients-with-tnbc-32495https://curecurrent.com/trials/accelerated-partial-breast-radiation-therapy-using-high-dose-rate-brachytherapy-in-treating-patients-with-early-stage-br-32496https://curecurrent.com/trials/effectiveness-validation-of-celbrea-in-symptomatic-women-or-with-diagnostic-doubt-of-breast-pathology-detect-bh-32497https://curecurrent.com/trials/exercise-based-cardiac-rehabilitation-for-the-prevention-of-breast-cancer-chemotherapy-induced-cardiotoxicity-32498https://curecurrent.com/trials/xoft-intraoperative-radiotherapy-iort-for-patients-with-early-stage-breast-cancer-32499https://curecurrent.com/trials/efficacy-and-safety-of-inetetamab-combined-with-pyrotinib-and-vinorelbine-in-abc-32500https://curecurrent.com/trials/phase-ii-study-of-t-dx-in-her2-positive-breast-cancer-brain-metastases-32501https://curecurrent.com/trials/rise-reduce-sitting-time-among-breast-cancer-survivors-32502https://curecurrent.com/trials/the-psychology-intervention-on-disease-acceptance-and-quality-of-life-in-breast-cancer-patients-32503https://curecurrent.com/trials/the-one-mind-study-evaluating-the-efficacy-of-online-mindfulness-based-cancer-recovery-during-chemotherapy-treatment-32504https://curecurrent.com/trials/technology-based-cancer-screening-intervention-32505https://curecurrent.com/trials/investigating-barriers-for-decision-making-in-a-danish-breast-cancer-screening-context-32506https://curecurrent.com/trials/telemonitoring-hypertension-and-breast-cancer-32507https://curecurrent.com/trials/a-descriptive-study-of-baseline-characteristics-clinical-outcomes-and-treatment-patterns-of-hr-her2-advanced-or-metastat-32508https://curecurrent.com/trials/comparative-study-between-shear-and-strain-elastography-in-monitoring-the-response-to-nac-in-breast-cancer-patients-32509https://curecurrent.com/trials/use-of-superparamagnetic-iron-oxide-spio-in-sentinel-lymph-node-detection-for-breast-cancer-32510https://curecurrent.com/trials/breast-cancer-and-sexuality-treatment-32511https://curecurrent.com/trials/chemotherapy-induced-peripheral-neuropathy-cipn-32512https://curecurrent.com/trials/the-relationships-between-physical-activity-level-quality-of-life-and-cognitive-level-in-breast-cancer-patients-32513https://curecurrent.com/trials/interventional-study-on-determinants-and-factors-of-physical-activity-after-treatments-in-oncology-32514https://curecurrent.com/trials/effects-of-continuous-and-interval-physical-training-through-the-intensity-of-the-incremental-shuttle-walk-test-on-funct-32515https://curecurrent.com/trials/culturally-appropriate-nutrition-communication-for-mexican-american-women-32516https://curecurrent.com/trials/effect-of-resveratrol-on-serum-igf2-among-african-american-women-32517https://curecurrent.com/trials/effectiveness-of-low-level-laser-therapy-on-insulin-resistance-and-inflammatory-biomarkers-32518https://curecurrent.com/trials/a-study-of-gb491-in-combination-with-letrozole-in-patients-with-hr-positive-and-her2-negative-advanced-breast-cancer-32519https://curecurrent.com/trials/comparison-of-positron-emission-mammography-and-contrast-enhanced-breast-mri-32520https://curecurrent.com/trials/prediction-of-axillary-lymph-node-metastasis-status-in-breast-cancer-based-on-pet-ct-radiomics-32521https://curecurrent.com/trials/pain-treatment-in-a-breast-cancer-population-pained-study-32522https://curecurrent.com/trials/acupuncture-in-reducing-muscle-and-bone-symptoms-in-women-receiving-letrozole-exemestane-or-anastrozole-for-stage-0-stag-32523https://curecurrent.com/trials/compare-outcomes-between-two-acellular-dermal-matrices-32524https://curecurrent.com/trials/efficacy-and-safety-of-trastuzumab-emtansine-in-chinese-participants-with-human-epidermal-growth-factor-receptor-2-her2-32525https://curecurrent.com/trials/skin-sensitivity-acupuncture-and-kinesiotherapy-on-breast-cancer-patients-subject-to-chemotherapy-with-taxans-32526https://curecurrent.com/trials/tip-in-patients-affected-by-metastatic-tnbc-32527https://curecurrent.com/trials/quality-of-life-after-conservative-oncoplastic-surgery-in-breast-cancer-patients-irony-life-after-oncoplastic-surgery-32528https://curecurrent.com/trials/zn-c3-for-the-treatment-of-metastatic-triple-negative-breast-cancer-and-advanced-ovarian-cancer-32529https://curecurrent.com/trials/a-phase-3-study-comparing-carelizumab-plus-nab-paclitaxel-and-apatinib-carelizumab-plus-nab-paclitaxel-and-nab-paclitaxe-32530https://curecurrent.com/trials/breast-cancer-anti-progestin-prevention-study-1-32531https://curecurrent.com/trials/digital-delivery-of-information-about-genetic-testing-for-breast-cancer-32532https://curecurrent.com/trials/influence-of-chemotherapy-on-postural-control-in-women-with-cancer-32533https://curecurrent.com/trials/azd5363-in-patients-with-advanced-solid-tumors-harboring-akt-mutations-32534https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-shr6390-combined-with-pyrotinib-in-her2-advanced-breast-cancer-32535https://curecurrent.com/trials/use-of-innovative-and-micro-invasive-techniques-for-the-early-identification-of-breast-cancer-patients-benefitting-from-32536https://curecurrent.com/trials/igf-level-in-breast-cancer-patients-treated-with-metformin-32537https://curecurrent.com/trials/open-label-phase-ii-study-of-everolimus-plus-letrozole-in-postmenopausal-women-with-er-her2-metastatic-or-locally-advanc-32538https://curecurrent.com/trials/efficacy-and-safety-of-intravenous-versus-oral-5-ht3-antagonists-combined-with-nk-1-receptor-antagonists-for-the-prevent-32539https://curecurrent.com/trials/pyrotinib-plus-trastuzumab-and-chemotherapy-in-her2-metastatic-breast-cancer-patients-32540https://curecurrent.com/trials/routine-evaluation-of-the-social-determinants-of-health-in-oncology-user-centered-resource-coordination-and-engagement-32541https://curecurrent.com/trials/fes-16-18f-fluoro-17-estradiol-pet-towards-a-new-standard-to-stage-locally-advanced-and-recurrent-estrogen-receptor-posi-32542https://curecurrent.com/trials/adjuvant-study-of-pyrotinib-in-combination-with-trastuzumab-in-her2-positive-invasive-breast-cancer-32543https://curecurrent.com/trials/ft500-as-monotherapy-and-in-combination-with-immune-checkpoint-inhibitors-in-subjects-with-advanced-solid-tumors-32544https://curecurrent.com/trials/a-phase-i-study-of-lx-039-tablets-32545https://curecurrent.com/trials/clinical-trial-evaluating-the-effectiveness-of-a-tattoo-compared-to-a-clip-applied-to-axillary-lymph-nodes-in-breast-can-32546https://curecurrent.com/trials/the-development-of-quantitative-ultrasound-imaging-software-platform-32547https://curecurrent.com/trials/intraoperative-detection-of-residual-cancer-in-breast-cancer-32548https://curecurrent.com/trials/a-study-of-epothilone-d-in-combination-with-herceptin-trastuzumab-in-patients-with-her-2-positive-advanced-or-metastatic-32549https://curecurrent.com/trials/her2-expression-of-ctc-to-predict-response-in-her2-low-advanced-breast-cancer-patients-treated-with-adc-32550https://curecurrent.com/trials/long-term-outcomes-of-breast-cancer-patients-after-wound-infiltration-analgesia-32551https://curecurrent.com/trials/association-of-silicone-breast-implants-with-overall-wellbeingand-auto-immune-diseases-32552https://curecurrent.com/trials/neoadjuvant-fluzoparib-in-germline-brca-mutated-three-negative-breast-cancer-breast-cancer-32553https://curecurrent.com/trials/erbb2-over-expressing-metastatic-breast-cancer-study-using-paclitaxel-trastuzumab-and-lapatinib-32554https://curecurrent.com/trials/a-study-of-letrozole-palbociclib-and-onapristone-er-in-people-with-metastatic-breast-cancer-32555https://curecurrent.com/trials/inherited-breast-cancer-italian-registry-a-retrospective-prospective-observational-cohort-study-to-evaluate-cancer-preve-32556https://curecurrent.com/trials/her2-expression-of-ctc-to-predict-response-in-her2-positive-advanced-breast-cancer-patients-treated-with-adc-32557https://curecurrent.com/trials/pyrotinib-in-women-with-high-risk-in-early-stage-breast-cancer-32558https://curecurrent.com/trials/surgery-to-remove-the-sentinel-lymph-node-and-axillary-lymph-nodes-after-chemotherapy-in-treating-women-with-stage-ii-st-32559https://curecurrent.com/trials/hr-her2-advanced-metastatic-breast-cancer-real-world-treatment-patterns-and-outcomes-32560https://curecurrent.com/trials/targeted-t-cells-after-neoadjuvant-chemotherapy-in-treating-women-with-stage-ii-or-iii-breast-cancer-undergoing-surgery-32561https://curecurrent.com/trials/second-line-eribulin-followed-by-capecitabine-or-the-reverse-sequence-in-her2-negative-metastatic-breast-cancer-patients-32562https://curecurrent.com/trials/evaluating-the-effectiveness-and-outcomes-of-silicone-breast-prosthetics-32563https://curecurrent.com/trials/computation-prediction-of-drug-response-based-on-omics-data-32564https://curecurrent.com/trials/the-use-of-virtual-reality-during-breast-ultrasound-guided-biopsy-procedures-32565https://curecurrent.com/trials/comparison-between-prepectoral-and-subpectoral-breast-reconstruction-32566https://curecurrent.com/trials/a-trial-evaluating-the-efficacy-and-safety-of-endotag-1-in-combination-with-paclitaxel-and-gemcitabine-compared-with-pac-32567https://curecurrent.com/trials/low-dose-imaging-technique-lite-32568https://curecurrent.com/trials/the-impact-of-inhalation-vs-total-intravenous-anesthesia-on-the-immune-status-and-mortality-in-patients-undergoing-breas-32569https://curecurrent.com/trials/olaparib-and-onalespib-in-treating-patients-with-solid-tumors-that-are-metastatic-or-cannot-be-removed-by-surgery-or-rec-32570https://curecurrent.com/trials/red-bull-energy-drink-intake-after-autologous-microsurgical-breast-reconstruction-32571https://curecurrent.com/trials/efficacy-of-supplement-adjuvant-capecitabine-in-hr-her2-breast-cancer-patients-with-high-risks-32572https://curecurrent.com/trials/pilot-study-of-single-port-robot-assisted-nipple-sparing-mastectomy-32573https://curecurrent.com/trials/positron-emission-tomograph-pet-imaging-explores-the-role-of-sf-devd-2-in-monitoring-tumor-efficacy-32574https://curecurrent.com/trials/methionine-restricted-diet-to-potentiate-the-effects-of-radiation-therapy-32575https://curecurrent.com/trials/single-cell-rnaseq-breast-cancer-32576https://curecurrent.com/trials/ipsilateral-peripheral-intravenous-access-procedures-the-ipivap-study-32577https://curecurrent.com/trials/a-phase-i-study-with-lymfactin-in-the-treatment-of-patients-with-secondary-lymphedema-32578https://curecurrent.com/trials/ang1005-in-leptomeningeal-disease-from-breast-cancer-32579https://curecurrent.com/trials/effects-of-probiotics-on-the-gut-microbiome-and-immune-system-in-operable-stage-i-iii-breast-or-lung-cancer-32580https://curecurrent.com/trials/study-evaluating-the-impact-of-electronic-surveys-on-patient-physician-communication-and-quality-of-life-in-breast-cance-32581https://curecurrent.com/trials/prevention-of-female-cancers-by-optimization-of-selenium-levels-in-the-organism-32582https://curecurrent.com/trials/accelerated-radiation-therapy-after-surgery-in-treating-patients-with-breast-cancer-32583https://curecurrent.com/trials/memantine-for-prevention-of-cognitive-decline-in-patients-with-breast-cancer-32584https://curecurrent.com/trials/impact-of-anticipated-regret-incorporation-into-patient-decision-aids-32585https://curecurrent.com/trials/safety-and-activity-study-of-her2-targeted-dual-switch-car-t-cells-bpx-603-in-subjects-with-her2-positive-solid-tumors-32586https://curecurrent.com/trials/npwt-for-abdominal-incisions-in-diep-reconstructions-a-rct-32587https://curecurrent.com/trials/radiomic-analysis-for-predicting-treatment-response-and-clinical-outcomes-in-malignancies-32588https://curecurrent.com/trials/phase-i-ii-study-of-interferon-gamma-in-patients-with-her-2-positive-breast-cancer-32589https://curecurrent.com/trials/pain-nutrition-and-glycemic-response-in-chronic-low-back-pain-and-breast-cancer-survivors-32590https://curecurrent.com/trials/neoadjuvant-biomarker-research-study-of-palbociclib-combined-with-endocrine-therapy-in-estrogen-receptor-positive-her2-n-32591https://curecurrent.com/trials/the-effect-of-rhomboid-intercostal-block-and-serratus-anterior-plane-block-on-postoperative-respiratory-functions-32592https://curecurrent.com/trials/novel-mri-techniques-on-evaluation-of-lymphedema-32593https://curecurrent.com/trials/hypertension-management-in-cancer-patients-32594https://curecurrent.com/trials/the-effect-of-yoga-therapy-on-post-operative-side-effects-among-women-with-breast-cancer-32595https://curecurrent.com/trials/breads-breast-adjuvant-diet-study-32596https://curecurrent.com/trials/assessing-immunoresponse-post-eribulin-eribulin-and-immunogenicity-in-advanced-breast-cancer-32597https://curecurrent.com/trials/quadratic-phenotypic-optimisation-platform-qpop-utilisation-to-enhance-selection-of-patient-therapy-through-patient-deri-32598https://curecurrent.com/trials/personalized-estimation-of-doses-delivered-during-image-guided-radiation-therapy-tests-32599https://curecurrent.com/trials/vaccine-therapy-with-or-without-polysaccharide-k-in-patients-with-stage-iv-her2-positive-breast-cancer-receiving-her2-ta-32600https://curecurrent.com/trials/lymphoma-patients-undergoing-mediastinal-radiotherapy-in-the-era-of-modern-chemoradiation-32601https://curecurrent.com/trials/herceptin-followed-by-chemotherapy-in-treating-women-with-metastatic-breast-cancer-that-overexpresses-her2-32602https://curecurrent.com/trials/supermicrosurgery-for-breast-cancer-survivors-with-lymphedema-32603https://curecurrent.com/trials/comprehensive-analysis-of-spatial-temporal-and-molecular-patterns-of-ribociclib-efficacy-and-resistance-in-advanced-brea-32604https://curecurrent.com/trials/neoadjuvant-ontruzant-sb3-in-patients-with-her2-positive-early-breast-cancer-an-open-label-neoon-32605https://curecurrent.com/trials/efficacy-of-parecoxib-combined-with-paracetamol-in-mastectomy-32606https://curecurrent.com/trials/potential-drug-interaction-between-alxn2040-and-rosuvastatin-32607https://curecurrent.com/trials/her2-expression-detection-in-breast-cancer-using-99mtc-nm-02-32608https://curecurrent.com/trials/chidamide-combined-with-fulvestrant-for-hr-her2-advanced-breast-cancer-32609https://curecurrent.com/trials/monitoring-luminal-breast-cancer-through-the-evaluation-of-mutational-and-epigenetic-alterations-of-circulating-esr1-dna-32610https://curecurrent.com/trials/a-study-of-etirinotecan-pegol-nktr-102-versus-treatment-of-physician-s-choice-tpc-in-patients-with-metastatic-breast-can-32611https://curecurrent.com/trials/pd-1-knockout-anti-muc1-car-t-cells-in-the-treatment-of-advanced-breast-cancer-32612https://curecurrent.com/trials/a-study-of-cobimetinib-plus-paclitaxel-cobimetinib-plus-atezolizumab-plus-paclitaxel-or-cobimetinib-plus-atezolizumab-pl-32613https://curecurrent.com/trials/a-study-of-shr6390-combined-with-famitinib-in-the-treatment-of-hr-her2-advanced-breast-cancer-32614https://curecurrent.com/trials/prone-whole-breast-radiationtherapy-versus-supine-whole-breast-radiation-therapy-imaging-32615https://curecurrent.com/trials/mechanism-exploration-of-anti-her-2-small-molecule-tyrosine-kinase-inhibitor-related-diarrhea-and-establishment-of-preve-32616https://curecurrent.com/trials/shr6390-combined-with-anastrozole-for-preoperative-treatment-of-breast-cancer-32617https://curecurrent.com/trials/moving-on-after-breast-cancer-plus-for-breast-cancer-survivors-32618https://curecurrent.com/trials/nr-in-chemo-induced-peripheral-neuropathy-32619https://curecurrent.com/trials/a-phase-ii-trial-of-camrelizumab-in-combination-with-apatinib-for-neoadjuvant-treatment-of-early-stage-tnbc-with-a-high-32620https://curecurrent.com/trials/select-the-appropriate-population-for-adding-cdk4-6i-to-neoadjuvant-endocrine-therapy-32621https://curecurrent.com/trials/oa-for-breast-cancer-nac-response-32622https://curecurrent.com/trials/a-phase-ii-trial-of-camrelizumab-in-combination-with-apatinib-and-eribulin-in-patients-with-advanced-tnbc-32623https://curecurrent.com/trials/effects-of-music-intervention-combined-with-progressive-muscle-relaxation-in-cancer-patients-32624https://curecurrent.com/trials/time-restricted-eating-in-survivors-trial-32625https://curecurrent.com/trials/prehabilitation-for-women-undergoing-pre-operative-chemotherapy-for-breast-cancer-32626https://curecurrent.com/trials/assessment-of-lumpectomy-margins-with-the-histolog-scanner-in-comparison-with-intraoperative-imaging-techniques-32627https://curecurrent.com/trials/radiomic-markers-for-breast-cancer-metastasis-and-treatment-response-using-mri-32628https://curecurrent.com/trials/evaluating-breast-cancer-patients-modesty-during-radiotherapy-a-multicentric-study-32629https://curecurrent.com/trials/alternative-exercise-program-to-improve-skeletal-muscle-function-and-fatigue-in-cancer-survivors-32630https://curecurrent.com/trials/streaming-web-based-exercise-at-home-a-pilot-study-32631https://curecurrent.com/trials/bintrafusp-alfa-in-high-mobility-group-at-hook-2-hmga2-expressing-triple-negative-breast-cancer-32632https://curecurrent.com/trials/prognostic-relevance-of-coagulation-activation-in-risk-assessment-and-stratification-32633https://curecurrent.com/trials/breast-cancer-pathways-program-impact-on-patient-shared-decision-making-and-experience-in-academic-and-community-practic-32634https://curecurrent.com/trials/dalpiciclib-plus-fulvestrant-with-pyrotinib-in-hormone-receptor-positive-her2-low-advanced-breast-cancer-that-progressed-32635https://curecurrent.com/trials/combination-of-chidamide-and-fulvestrant-for-hr-her2-breast-cancer-that-has-failed-previous-cdk4-6-i-adjuvant-therapy-32636https://curecurrent.com/trials/detection-of-germline-and-somatic-pathogenic-variants-in-patients-with-de-novo-metastatic-breast-cancer-32637https://curecurrent.com/trials/tell-us-your-food-story-32638https://curecurrent.com/trials/optical-surface-monitoring-technology-guided-large-segment-radiotherapy-for-breast-cancer-32639https://curecurrent.com/trials/deformable-image-registration-for-breast-adaptive-tomotherapy-32640https://curecurrent.com/trials/effects-of-physiotherapy-in-the-treatment-of-lymphedema-after-breast-cancer-32641https://curecurrent.com/trials/iribrine-plus-tucidinostat-in-the-treatment-of-hr-her2-advanced-breast-cancer-after-cdk4-6-inhibitor-failure-32642https://curecurrent.com/trials/aerobic-training-in-metastatic-breast-cancer-32643https://curecurrent.com/trials/pyrotinib-combined-with-trastuzumab-dalpiciclib-and-letrozole-for-hr-her2-breast-cancer-32644https://curecurrent.com/trials/neoadjuvant-endocrine-therapy-in-breast-cancer-real-clinical-practice-in-russia-32645https://curecurrent.com/trials/a-multicenter-randomized-double-blind-phase-ii-trial-to-evaluate-gm1-prevention-of-peripheral-neuropathy-in-patients-wit-32646https://curecurrent.com/trials/surufatinib-combined-with-tislelizumab-in-the-second-line-and-further-treatment-of-triple-negative-breast-cancer-32647https://curecurrent.com/trials/tissue-expander-breast-reconstruction-study-on-breast-volume-and-shape-change-32648https://curecurrent.com/trials/phase-iii-to-evaluate-patient-s-preference-of-subcutaneous-trastuzumab-vs-intravenous-in-her2-advanced-breast-cancer-32649https://curecurrent.com/trials/trial-of-intratumoral-injections-of-tti-621-in-subjects-with-relapsed-and-refractory-solid-tumors-and-mycosis-fungoides-32650https://curecurrent.com/trials/automated-breast-ultrasound-screening-32651https://curecurrent.com/trials/topical-menthol-application-in-chemotherapy-related-peripheral-neuropathy-in-patients-with-breast-cancer-32652https://curecurrent.com/trials/real-world-effectiveness-and-safety-study-of-t-dxd-in-chinese-metastatic-breast-cancer-32653https://curecurrent.com/trials/to-assess-immunogenicity-of-coronavirus-disease-2019-covid-19-vaccine-in-cancer-patients-receiving-cancer-treatment-32654https://curecurrent.com/trials/cedm-as-a-screening-tool-for-breast-cancer-in-higher-risk-women-a-prospective-study-32655https://curecurrent.com/trials/caelyx-cyclophosphamide-and-herceptin-in-patients-with-metastatic-breast-cancer-32656https://curecurrent.com/trials/docetaxel-doxorubicin-a-cyclophosphamide-c-tac-vs-5-fluorouracil-a-c-5fac-breast-cancer-adjuvant-treatment-32657https://curecurrent.com/trials/randomized-and-multicenter-study-to-evaluate-a-customizable-support-breast-cancer-material-32658https://curecurrent.com/trials/optical-spectroscopy-in-evaluating-tumor-margins-in-patients-who-have-undergone-surgery-for-breast-tumors-32659https://curecurrent.com/trials/selective-neoadjuvant-treatment-according-to-immunohistochemical-subtype-for-her2-negative-breast-cancer-patients-32660https://curecurrent.com/trials/automated-low-dose-risk-assessment-mammography-aldram-32661https://curecurrent.com/trials/trial-to-evaluate-efficacy-and-safety-of-pembrolizumab-and-gemcitabine-in-her2-negative-abc-32662https://curecurrent.com/trials/epidemiology-of-breast-cancer-in-women-based-on-diagnosis-data-from-oncologists-and-breast-surgeons-in-algeria-32663https://curecurrent.com/trials/study-of-lde225-sonidegib-in-combination-with-docetaxel-in-triple-negative-tn-advanced-breast-cancer-abc-patients-32664https://curecurrent.com/trials/a-phase-b-clinical-study-of-shr-a1811-combined-with-other-therapies-in-patients-with-her2-low-advanced-or-metastatic-bre-32665https://curecurrent.com/trials/abemaciclib-for-the-treatment-of-luminal-metastatic-breast-cancer-in-the-real-life-clinical-practice-in-russia-32666https://curecurrent.com/trials/ec-followed-docetaxel-versus-et-followed-capecitabine-as-adjuvant-chemotherapy-for-node-positive-operable-breast-cancer-32667https://curecurrent.com/trials/patterns-of-prescribing-and-monitoring-of-palbociclib-32668https://curecurrent.com/trials/maintenance-treatment-with-capecitabine-versus-observation-in-breast-cancer-patients-32669https://curecurrent.com/trials/investigation-of-a-digital-healthy-habits-program-for-individuals-with-breast-cancer-32670https://curecurrent.com/trials/trastuzumab-versus-lapatinib-as-neoadjuvant-treatment-for-her2-patients-32671https://curecurrent.com/trials/gw572016-with-docetaxel-and-trastuzumab-for-the-treatment-of-untreated-erbb2-over-expressing-metastatic-breast-cancer-32672https://curecurrent.com/trials/photoacoustic-imaging-in-diagnosing-changes-in-tumors-in-participants-with-breast-cancer-sarcoma-skin-cancer-or-soft-tis-32673https://curecurrent.com/trials/bevacizumab-endocrine-treatment-vs-endocrine-treatment-as-first-line-in-postmenopausal-women-32674https://curecurrent.com/trials/effects-o-laughing-qigong-program-on-psychological-outcomes-and-the-physiological-immunological-responses-32675https://curecurrent.com/trials/supporting-women-with-breast-cancer-to-practice-dibh-at-home-before-radiation-therapy-32676https://curecurrent.com/trials/evaluating-the-shared-decision-making-process-scale-in-cancer-screening-decisions-32677https://curecurrent.com/trials/melatonin-supplementation-for-cancer-related-fatigue-in-patients-receiving-radiotherapy-32678https://curecurrent.com/trials/dasatinib-in-combination-with-trastuzumab-and-paclitaxel-in-first-line-treatment-of-her2-positive-mbc-patients-32679https://curecurrent.com/trials/study-to-evaluate-the-feasibility-of-13-c-pyruvate-imaging-in-breast-cancer-patients-receiving-neoadjuvant-chemotherapy-32680https://curecurrent.com/trials/neoadjuvant-treatment-with-nab-paclitaxel-for-patients-with-stage-ii-and-iii-luminal-breast-cancer-32681https://curecurrent.com/trials/panitumumab-nab-paclitaxel-and-carboplatin-for-her2-negative-inflammatory-breast-cancer-32682https://curecurrent.com/trials/pegylated-liposomal-doxorubicin-hydrochloride-and-carboplatin-followed-by-surgery-and-paclitaxel-in-treating-patients-wi-32683https://curecurrent.com/trials/clinical-evaluation-of-opto-acoustic-image-quality-with-the-gen-2-imagio-system-32684https://curecurrent.com/trials/acceptance-and-usability-of-an-app-promoting-healthy-behaviours-amongst-young-women-at-increased-risk-of-breast-cancer-32685https://curecurrent.com/trials/gemcitabine-imatinib-mesylate-patients-w-previously-treated-metastatic-breast-cancer-32686https://curecurrent.com/trials/comparison-of-safety-and-clinical-benefit-of-injections-subcutaneously-talazoparib-versus-oral-talazoparib-in-patients-w-32687https://curecurrent.com/trials/effectiveness-and-safety-study-of-filgrastine-in-patientes-with-breast-cancer-treated-with-myelotoxic-chemotherapy-32688https://curecurrent.com/trials/oxygen-partial-pressure-after-breast-cancer-surgery-32689https://curecurrent.com/trials/radiotherapy-alternates-human-epidermal-growth-factor-2-her2-expression-in-human-breast-cancer-32690https://curecurrent.com/trials/pain-neuroscience-education-and-therapeutic-exercise-as-a-treatment-for-breast-cancer-survivors-living-with-sequelae-32691https://curecurrent.com/trials/co-moon-for-supporting-breast-cancer-patients-on-adjuvant-endocrine-therapy-32692https://curecurrent.com/trials/neugranin-in-breast-cancer-participants-receiving-doxorubicin-docetaxel-32693https://curecurrent.com/trials/genetic-susceptibility-to-radiation-induced-skin-reactions-in-racial-ethnic-groups-of-patients-with-breast-cancer-32694https://curecurrent.com/trials/a-pilot-study-utilizing-proteomic-and-genomic-profiling-for-patients-with-metastatic-breast-cancer-32695https://curecurrent.com/trials/pamidronate-administration-in-breast-cancer-patients-with-bone-metastases-32696https://curecurrent.com/trials/tibetan-yoga-in-improving-fatigue-and-sleep-in-participants-with-stage-i-iii-breast-cancer-32697https://curecurrent.com/trials/inetetamab-combined-with-pyrotinib-and-vinorelbine-as-first-line-to-third-line-treatment-for-her2-positive-metastatic-br-32698https://curecurrent.com/trials/b002-in-patients-with-her2-positive-breast-cancer-32699https://curecurrent.com/trials/gender-difference-in-side-effects-of-immunotherapy-a-possible-clue-to-optimize-cancer-treatment-32700https://curecurrent.com/trials/hoboe-a-phase-3-study-of-adjuvant-triptorelin-and-tamoxifen-letrozole-or-letrozole-and-zoledronic-acid-in-premenopausal-32701https://curecurrent.com/trials/a-study-of-edp1503-in-patients-with-colorectal-cancer-breast-cancer-and-checkpoint-inhibitor-relapsed-tumors-32702https://curecurrent.com/trials/specialist-recommendation-on-fbc-familial-breast-cancer-chemoprevention-prescribing-32703https://curecurrent.com/trials/vincat-vinorelbine-carboplatin-and-trastuzumab-in-advanced-her-2-positive-breast-cancer-32704https://curecurrent.com/trials/investigation-of-urinary-biomarkers-for-the-detection-of-breast-cancer-32705https://curecurrent.com/trials/pfmt-educational-intervention-for-patients-with-advancer-breast-cancer-32706https://curecurrent.com/trials/supervised-exercise-to-promote-infiltration-of-nk-cells-into-the-tumor-32707https://curecurrent.com/trials/efficacy-evaluation-of-sabizabulin-monotherapy-versus-active-control-for-treatment-of-er-her2-metastatic-breast-cancer-32708https://curecurrent.com/trials/the-efficacy-and-safety-of-eutideron-etoposide-and-bevacizumab-in-patients-with-brain-metastases-from-breast-cancer-32709https://curecurrent.com/trials/patient-centered-breast-cancer-teleprehabilitation-32710https://curecurrent.com/trials/a-study-of-sgn-cd228a-in-advanced-solid-tumors-32711https://curecurrent.com/trials/establishment-of-a-tumor-bank-for-blood-samples-32712https://curecurrent.com/trials/effect-of-methylphenidate-on-cancer-related-cognitive-impairment-32713https://curecurrent.com/trials/the-effect-of-virtual-reality-on-anxiety-and-fatigue-in-women-with-breast-cancer-receiving-adjuvant-chemotherapy-32714https://curecurrent.com/trials/establishment-of-a-tumor-bank-for-tissue-samples-32715https://curecurrent.com/trials/a-study-in-hormone-receptor-positive-metastatic-breast-carcinoma-patients-to-test-a-new-schedule-of-efti-imp321-eftilagi-32716https://curecurrent.com/trials/surpass-retrospective-study-32717https://curecurrent.com/trials/intraoperative-use-of-clearedge-device-in-breast-conserving-surgery-32718https://curecurrent.com/trials/radiation-doses-and-fractionation-schedules-in-non-low-risk-ductal-carcinoma-in-situ-dcis-of-the-breast-32719https://curecurrent.com/trials/health-technologies-readiness-in-breast-cancer-patients-32720https://curecurrent.com/trials/efficacy-of-exercise-using-connected-activity-trackers-and-therapeutic-education-in-localized-breast-cancer-32721https://curecurrent.com/trials/patient-characteristics-treatment-patterns-and-clinical-outcomes-in-patients-diagnosed-with-hr-her2-advanced-metastatic-32722https://curecurrent.com/trials/exercise-intervention-in-preventing-breast-cancer-recurrence-in-postmenopausal-breast-cancer-survivors-32723https://curecurrent.com/trials/pol6326-balixafortide-plus-nab-paclitaxel-or-eribulin-in-patients-with-her2-negative-advanced-breast-cancer-32724https://curecurrent.com/trials/parp-inhibition-during-pre-surgical-window-in-breast-ovary-cancer-32725https://curecurrent.com/trials/fractional-co2-laser-therapy-for-survivors-of-breast-malignancies-32726https://curecurrent.com/trials/standard-silicone-based-vs-b-lite-light-weight-breast-implant-after-total-mastectomy-and-radiotherapy-for-breast-cancer-32727https://curecurrent.com/trials/pyrotinib-combined-with-trastuzumab-dalpiciclib-letrozole-versus-tcbhp-trastuzumab-plus-pertuzumab-with-docetaxel-and-ca-32728https://curecurrent.com/trials/the-effects-of-upper-extremity-lymphedema-on-posture-upper-extremity-functions-and-quality-of-life-32729https://curecurrent.com/trials/a-clinical-trial-of-tqb3909-tablets-in-patients-with-breast-cancer-32730https://curecurrent.com/trials/project-cadence-cancer-detected-early-can-be-cured-32731https://curecurrent.com/trials/nicotinamide-riboside-and-prevention-of-cancer-therapy-related-cardiac-dysfunction-in-breast-cancer-patients-32732https://curecurrent.com/trials/a-study-of-mrg002-in-the-treatment-of-patients-with-her2-positive-unresectable-locally-advanced-or-metastatic-breast-can-32733https://curecurrent.com/trials/lynparza-breast-cancer-clinical-experience-investigation-32734https://curecurrent.com/trials/uk-ibrance-patient-program-ipp-study-32735https://curecurrent.com/trials/circular-rna-and-chemerin-in-breast-cancer-patient-32736https://curecurrent.com/trials/mobile-application-support-for-women-with-breast-cancer-undergoing-chemotherapy-32737https://curecurrent.com/trials/contrast-enhanced-cone-beam-breast-ct-for-diagnostic-breast-imaging-32738https://curecurrent.com/trials/a-randomized-study-comparing-the-immune-modulation-effect-of-ribociclib-palbociclib-and-abemaciclib-in-er-her2-ebc-32739https://curecurrent.com/trials/a-study-of-prt1419-in-patients-with-advanced-solid-tumors-32740https://curecurrent.com/trials/clinical-study-to-evaluate-safety-and-dosing-of-ca9hu-1-in-patients-with-advanced-solid-tumours-32741https://curecurrent.com/trials/efficacy-of-cilostazol-in-prevention-of-peripheral-neuropathy-32742https://curecurrent.com/trials/healthy-lifestyles-and-quality-of-life-in-women-with-breast-cancer-32743https://curecurrent.com/trials/looking-at-triple-negative-breast-cancer-patient-experience-patterns-in-medical-trials-32744https://curecurrent.com/trials/a-study-of-the-safety-efficacy-and-pharmacokinetics-of-tiragolumab-in-combination-with-atezolizumab-and-chemotherapy-in-32745https://curecurrent.com/trials/feasibility-of-an-individualized-goals-of-care-discussion-guide-for-advanced-breast-cancer-32746https://curecurrent.com/trials/effect-of-perioperative-cbt-on-chronic-persistent-postsurgical-pain-among-breast-cancer-patients-32747https://curecurrent.com/trials/ultrasound-radiomics-for-predicting-breast-cancer-and-axillary-lymph-node-metastasis-32748https://curecurrent.com/trials/the-role-of-genetic-factors-in-the-development-of-breast-cancer-in-the-kazakh-population-32749https://curecurrent.com/trials/artificial-intelligence-in-large-scale-breast-cancer-screening-32750https://curecurrent.com/trials/development-of-multi-specific-antibodies-based-on-immune-microenvironment-of-breast-cancer-32751https://curecurrent.com/trials/a-dose-escalation-and-cohort-expansion-study-of-nktr-214-in-combination-with-nivolumab-and-other-anti-cancer-therapies-i-32752https://curecurrent.com/trials/an-online-psychosocial-intervention-for-fear-of-cancer-recurrence-in-breast-cancer-survivors-32753https://curecurrent.com/trials/study-in-women-with-advanced-breast-cancer-receiving-palbociclib-with-ai-or-fulvestrant-32754https://curecurrent.com/trials/clinical-study-to-compare-the-pharmacokinetics-and-safety-of-trastuzumab-for-injection-with-herceptin-in-healthy-male-vo-32755https://curecurrent.com/trials/circulating-tumor-cells-screen-for-breast-cancer-32756https://curecurrent.com/trials/phase-ii-study-of-lu177dotatoc-in-adults-with-sttr-pulmonary-pheochromocytoma-paraganglioma-unknown-primary-thymus-nets-32757https://curecurrent.com/trials/a-study-of-giredestrant-gdc-9545-in-postmenopausal-women-with-stage-i-iii-operable-estrogen-receptor-positive-breast-can-32758https://curecurrent.com/trials/diep-flap-surgery-and-intraabdominal-pressure-32759https://curecurrent.com/trials/fulvestrant-versus-fulvestrant-plus-palbociclib-in-operable-breast-cancer-responding-to-fulvestrant-32760https://curecurrent.com/trials/study-of-shr6390-in-renal-insufficiency-and-healthy-subjects-32761https://curecurrent.com/trials/evaluation-of-degree-of-conversion-of-her2-receptor-between-primary-breast-cancer-and-metastasis-32762https://curecurrent.com/trials/optimization-of-remotely-delivered-physical-activity-intervention-for-breast-cancer-survivors-32763https://curecurrent.com/trials/sentinel-node-biopsy-in-breast-cancner-omission-of-axillary-clearance-after-micrometastasis-32764https://curecurrent.com/trials/fulvestrant-faslodex-anastrozole-arimidex-vs-anastrozole-32765https://curecurrent.com/trials/application-of-radiomics-in-breast-cancer-32766https://curecurrent.com/trials/breast-cancer-after-ovarian-cancer-during-and-or-after-therapy-genomic-evaluation-32767https://curecurrent.com/trials/ultra-hypofractionated-adjuvant-radiotherapy-simultaneous-integrated-boost-for-low-risk-breast-cancer-patients-32768https://curecurrent.com/trials/neoadjuvant-hormonal-therapy-plus-palbociclib-in-operable-hormone-sensitive-and-her2-negative-primary-breast-cancer-32769https://curecurrent.com/trials/comparison-of-the-efficacy-and-tolerability-of-femal-versus-placebo-32770https://curecurrent.com/trials/the-effect-of-training-given-by-mobile-application-to-women-undergoing-breast-surgery-32771https://curecurrent.com/trials/neoadjuvant-camrelizumab-and-fluzoparib-and-nab-paclitaxel-in-early-breast-cancer-with-hrr-gene-mutation-32772https://curecurrent.com/trials/efficacy-of-metformin-as-preventive-treatment-in-paclitaxel-induced-peripheral-neuropathy-in-breast-cancer-patients-32773https://curecurrent.com/trials/acupuncture-treatment-of-vasomotor-symptoms-in-breast-cancer-patients-32774https://curecurrent.com/trials/investigation-of-gene-mutations-in-patients-with-triple-negative-and-patients-with-her2-breast-cancer-adenocarcinoma-32775https://curecurrent.com/trials/investigation-of-genomic-alteration-in-patients-with-luminal-a-or-luminal-b-subtypes-32776https://curecurrent.com/trials/reveal-study-of-nktr-262-in-combination-with-nktr-214-and-nivolumab-in-patients-with-locally-advanced-metastatic-solid-t-32777https://curecurrent.com/trials/cognitive-processing-slowness-as-a-marker-of-cognitive-impairment-in-non-central-nervous-system-cancer-patients-32778https://curecurrent.com/trials/immunological-variables-associated-to-ici-toxicity-in-cancer-patients-32779https://curecurrent.com/trials/improving-exercise-capacity-with-tailored-physical-activity-in-lymphoma-breast-cancer-patients-undergoing-tx-32780https://curecurrent.com/trials/pyrotinib-dalpiciclib-shr6390-and-endocrine-therapy-in-subjects-with-dual-receptor-positive-er-her2-advanced-breast-canc-32781https://curecurrent.com/trials/effectiveness-and-safety-of-preoperative-magnetic-detection-of-non-palpable-breast-lesions-32782https://curecurrent.com/trials/satisfaction-survey-for-the-outpatient-unit-dedicated-to-post-cancer-treatment-32783https://curecurrent.com/trials/a-safety-study-of-sgn-liv1a-in-breast-cancer-patients-32784https://curecurrent.com/trials/incidence-of-chemotherapy-induced-nausea-and-vomiting-associated-with-docetaxel-cyclophosphamide-in-early-breast-cancer-32785https://curecurrent.com/trials/prevalence-and-risk-factors-for-pain-and-related-adverse-reactions-among-breast-cancer-survivors-on-aromatase-inhibitors-32786https://curecurrent.com/trials/study-of-web-based-decision-aids-for-increasing-breast-cancer-chemoprevention-in-the-primary-care-setting-32787https://curecurrent.com/trials/construction-of-an-ultrasound-profile-and-a-mammographic-profile-corresponding-to-the-different-molecular-subtypes-of-br-32788https://curecurrent.com/trials/autohypnosis-and-cancerology-32789https://curecurrent.com/trials/fac-versus-fac-plus-weekly-paclitaxel-as-adjuvant-treatment-of-node-negative-high-risk-breast-cancer-patients-32790https://curecurrent.com/trials/breast-cancer-self-efficacy-scale-for-partners-32791https://curecurrent.com/trials/the-effect-of-mindfulness-program-on-spiritual-well-beingbreast-cancer-patients-32792https://curecurrent.com/trials/fluorouracil-epirubicin-and-cyclophosphamide-alone-or-followed-by-paclitaxel-for-early-breast-cancer-32793https://curecurrent.com/trials/study-of-the-utility-of-the-bomet-qol-questionnaire-patients-with-breast-cancer-and-bone-metastasis-32794https://curecurrent.com/trials/exemestane-versus-anastrozole-as-first-line-hormone-therapy-in-postmenopausal-metastatic-breast-cancer-patients-32795https://curecurrent.com/trials/study-of-neoadjuvant-chemotherapy-plus-trastuzumab-and-pertuzumab-in-her2-negative-breast-cancer-patients-with-abnormal-32796https://curecurrent.com/trials/retrospective-observational-study-about-evolution-of-patients-with-breast-cancer-in-hospitals-from-geicam-group-32797https://curecurrent.com/trials/efficacy-of-neoadjuvant-endocrine-therapy-compared-to-chemotherapy-in-breast-cancer-patients-32798https://curecurrent.com/trials/maintenance-treatment-with-liposomal-doxorubicin-caelyx-in-metastatic-breast-cancer-patients-32799https://curecurrent.com/trials/gemcitabine-doxorubicin-and-paclitaxel-gat-as-neoadjuvant-treatment-of-breast-cancer-patients-32800https://curecurrent.com/trials/estimation-of-the-prevalence-of-her2-low-and-describe-the-soc-treatment-patterns-and-outcome-in-real-world-practice-amon-32801https://curecurrent.com/trials/neoadjuvant-chemotherapy-with-myocet-taxotere-herceptin-for-her2-positive-breast-cancer-patients-32802https://curecurrent.com/trials/tumor-characteristics-and-survival-rate-of-her2-low-breast-cancer-patients-32803https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-in-patients-with-advanced-breast-cancer-treated-with-syhx2011-compared-to-pa-32804https://curecurrent.com/trials/a-phase-i-ii-study-of-regorafenib-plus-avelumab-in-solid-tumors-32805https://curecurrent.com/trials/exercise-in-breast-cancer-survivors-32806https://curecurrent.com/trials/observational-study-of-effectiveness-and-safety-of-trastuzumab-emtansine-t-dm1-in-her2-positive-breast-cancer-patients-w-32807https://curecurrent.com/trials/reliability-and-reproducibility-of-bandaging-in-breast-cancer-32808https://curecurrent.com/trials/a-pilot-study-of-monitoring-insulin-levels-and-treating-hyperinsulinemia-and-hyperglycemia-with-pioglitazone-in-patients-32809https://curecurrent.com/trials/cryoablation-as-a-minimally-invasive-alternative-to-surgery-for-managing-ductal-carcinoma-in-situ-32810https://curecurrent.com/trials/tac-versus-tc-for-adjuvant-breast-cancer-32811https://curecurrent.com/trials/pik3ca-in-her2-bc-and-pcr-trial-32812https://curecurrent.com/trials/stakeholder-assessment-of-implementing-the-commission-on-cancer-operative-standards-for-cancer-surgery-32813https://curecurrent.com/trials/brca-and-nact-in-tnbc-patients-32814https://curecurrent.com/trials/neoadjuvant-inetetamab-combined-with-pertuzumab-and-paclitaxel-carboplatin-for-breast-cancer-32815https://curecurrent.com/trials/chidamide-plus-pd-1-plus-paclitaxel-of-neoadjuvant-treatment-in-low-hr-expression-her2-negative-early-breast-cancer-32816https://curecurrent.com/trials/web-based-family-history-tool-32817https://curecurrent.com/trials/letrozole-plus-metronomic-capecitabine-as-first-line-treatment-for-patients-with-recurrent-or-metastatic-breast-cancer-32818https://curecurrent.com/trials/evaluating-mass-spectrometry-and-intraoperative-mri-in-the-advanced-multimodality-image-guided-operating-suite-amigo-in-32819https://curecurrent.com/trials/oral-vinorelbine-and-capecitabine-in-advanced-her2-negative-breast-cancer-32820https://curecurrent.com/trials/chidamide-in-combination-with-vincristine-metronomic-chemotherapy-for-advanced-triple-negative-breast-cancer-32821https://curecurrent.com/trials/a-trial-exploring-the-opportune-administration-of-nab-paclitaxel-in-the-first-line-treatment-camrelizumab-combined-with-32822https://curecurrent.com/trials/photobiomodulation-therapy-for-the-management-of-breast-cancer-related-lymphedema-32823https://curecurrent.com/trials/prospective-collection-of-surplus-surgical-tumor-tissues-and-pre-surgical-blood-samples-32824https://curecurrent.com/trials/identification-of-new-prognostic-markers-for-breast-cancer-32825https://curecurrent.com/trials/arginase-1-peptide-vaccine-in-patients-with-metastatic-solid-tumors-32826https://curecurrent.com/trials/omega-3-supplementation-in-prevention-of-aromatase-inhibitor-induced-toxicity-in-patients-with-stage-i-iii-breast-cancer-32827https://curecurrent.com/trials/longitudinal-evaluation-of-taxane-induced-neuropathy-in-early-stage-breast-cancer-32828https://curecurrent.com/trials/cancer-adverse-effects-prevention-with-care-exercise-the-caprice-study-32829https://curecurrent.com/trials/clinical-trial-to-assess-efficacy-and-safety-of-nng-tmab-trastuzumab-on-recurrent-or-metastatic-breast-cancer-patients-32830https://curecurrent.com/trials/monitoring-response-to-neoadjuvant-chemotherapy-in-breast-cancer-using-ultrafast-dce-mri-32831https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerability-of-using-shr-1210-by-advanced-solid-tumor-subjects-32832https://curecurrent.com/trials/facilitate-and-sustain-return-to-work-after-breast-cancer-32833https://curecurrent.com/trials/omega-3-fatty-acids-in-preventing-joint-symptoms-in-patients-with-stage-i-iii-breast-cancer-receiving-anastrozole-exemes-32834https://curecurrent.com/trials/a-study-of-alrn-6924-for-protection-of-chemotherapy-induced-side-effects-in-patients-with-tp53-mutant-breast-cancer-32835https://curecurrent.com/trials/the-safety-and-pharmacokinetics-preliminary-efficacy-of-imp7068-in-patients-with-advanced-solid-tumors-32836https://curecurrent.com/trials/circulating-tumor-dna-monitoring-in-breast-cancer-undergoing-neoadjuvant-therapy-32837https://curecurrent.com/trials/consciousness-based-ayurveda-lifestyle-program-for-improving-quality-of-life-in-survivors-of-breast-cancer-32838https://curecurrent.com/trials/clinical-study-of-glycosylated-extracellular-vesicles-for-early-diagnosis-of-breast-cancer-32839https://curecurrent.com/trials/preoperative-stereotactic-ablative-body-radiotherapy-sabr-for-early-stage-breast-cancer-32840https://curecurrent.com/trials/injection-regimen-trial-of-peg-rhg-csf-during-breast-cancer-chemotherapy-32841https://curecurrent.com/trials/cardioprotective-effects-of-nebivolol-versus-placebo-in-patients-undergoing-chemotherapy-with-anthracyclines-32842https://curecurrent.com/trials/memory-training-intervention-for-breast-cancer-survivors-32843https://curecurrent.com/trials/biobehavioral-correlates-of-cancer-related-cognitive-dysfunction-and-its-co-occurring-symptoms-32844https://curecurrent.com/trials/transdermal-or-oral-telapristone-acetate-in-treating-patients-undergoing-mastectomy-32845https://curecurrent.com/trials/a-two-stage-simon-design-phase-ii-study-for-non-brca-mbc-patients-with-hrd-treated-with-olaparib-single-agent-32846https://curecurrent.com/trials/a-double-blind-comparative-randomized-clinical-study-of-the-pharmacokinetics-safety-and-immunogenicity-of-a-single-intra-32847https://curecurrent.com/trials/dedicated-breast-pet-mri-in-evaluation-of-extent-of-disease-in-women-with-newly-diagnosed-breast-cancer-32848https://curecurrent.com/trials/clinical-application-of-dual-sentinel-lymph-node-staining-method-in-breast-cancer-patients-32849https://curecurrent.com/trials/olaparib-trastuzumab-in-her2-breast-cancer-susceptibility-gene-brca-mutated-advanced-breast-cancer-32850https://curecurrent.com/trials/pembrolizumab-and-exemestane-leuprolide-in-premenopausal-hr-her2-locally-advanced-or-metastatic-breast-cancer-32851https://curecurrent.com/trials/lifestyle-exercise-and-nutrition-study-2-lean-2-32852https://curecurrent.com/trials/tucidinostat-and-nab-paclitaxel-in-advanced-hr-her2-breast-cancer-32853https://curecurrent.com/trials/different-durations-of-adjuvant-anastrozole-therapy-after-2-to-3-years-tamoxifen-therapy-in-breast-cancer-32854https://curecurrent.com/trials/dalpiciclib-in-combination-with-exemestane-and-trastuzumab-plus-pyrotinib-in-early-triple-positive-breast-cancer-32855https://curecurrent.com/trials/the-effect-of-guided-imagery-based-on-the-health-promotion-model-on-the-quality-of-life-in-breast-cancer-patients-32856https://curecurrent.com/trials/liquid-biopsy-intercepting-mutational-trajectories-of-her2-human-epidermal-growth-factor-receptor-2-breast-cancer-gim21-32857https://curecurrent.com/trials/biological-characteristics-of-older-women-70-years-with-er-positive-her2-negative-early-breast-cancer-32858https://curecurrent.com/trials/phase-ii-trial-of-talazoparib-in-brca1-2-wild-type-her2-negative-breast-cancer-and-other-solid-tumors-32859https://curecurrent.com/trials/a-prospective-phase-ii-trial-using-ctdna-to-initiate-post-operation-boost-therapy-after-nac-in-tnbc-32860https://curecurrent.com/trials/bringing-of-pet-tdm-fdg-in-the-determination-of-the-characteristics-of-primary-mammary-tumors-triple-negatives-32861https://curecurrent.com/trials/a-prospective-phase-ii-trial-using-ctdna-to-initiate-post-operation-boost-therapy-after-adjuvant-chemotherapy-in-tnbc-32862https://curecurrent.com/trials/clinical-study-of-pyrotinib-in-neoadjuvant-therapy-of-hr-positive-and-her2-positive-breast-cancer-32863https://curecurrent.com/trials/18f-dpa-714-pet-ct-positron-emission-tomography-computerized-tomography-in-triple-negative-breast-cancers-32864https://curecurrent.com/trials/a-prospective-trial-to-compare-deep-inspiratory-breath-hold-dibh-with-prone-breast-irradiation-32865https://curecurrent.com/trials/hemopatch-versus-axillary-drainage-after-axillary-lymphadenectomy-32866https://curecurrent.com/trials/effect-of-genetic-and-epigenetic-factors-on-the-clinical-response-and-toxicity-to-doxorubicin-among-egyptian-breast-canc-32867https://curecurrent.com/trials/sintilimab-and-bevacizumab-biosimilar-combined-with-pld-in-mtnbc-32868https://curecurrent.com/trials/momentum-project-heidelberg-dealing-actively-with-a-cancerous-disease-32869https://curecurrent.com/trials/prospective-observational-study-of-adjuvant-hormone-treatment-in-estrogen-receptor-positive-premenopausal-early-breast-c-32870https://curecurrent.com/trials/relationship-between-breast-cancer-subtypes-and-immune-checkpoints-32871https://curecurrent.com/trials/observational-of-adjuvant-treatment-of-breast-cancer-with-liposomal-doxorubicin-regimen-32872https://curecurrent.com/trials/tad-in-primary-breast-cancer-with-initially-3-suspicious-lymph-nodes-32873https://curecurrent.com/trials/effects-of-clinical-pilates-and-yoga-training-in-lymphedema-32874https://curecurrent.com/trials/g1t38-a-cdk-4-6-inhibitor-in-combination-with-fulvestrant-in-hormone-receptor-positive-her2-negative-locally-advanced-or-32875https://curecurrent.com/trials/treatment-of-canadian-men-and-pre-peri-post-menopausal-women-with-er-advanced-breast-cancer-in-the-real-world-setting-wi-32876https://curecurrent.com/trials/change-in-cardiorespiratory-fitness-and-breast-cancer-incidence-and-mortality-32877https://curecurrent.com/trials/to-detect-cryoimmunologic-response-induced-by-early-breast-cancer-ultrasound-guided-cryoablation-ice-study-32878https://curecurrent.com/trials/effect-of-kinesiotaping-augmented-by-resistive-exercise-on-fatigue-physical-strength-quality-of-life-in-breast-cancer-su-32879https://curecurrent.com/trials/viral-therapy-in-treating-patients-with-recurrent-or-metastatic-squamous-cell-carcinoma-of-the-head-and-neck-cancer-or-m-32880https://curecurrent.com/trials/evaluation-of-myocardial-changes-during-breast-adenocarcinoma-therapy-to-detect-cardiotoxicity-earlier-with-mri-32881https://curecurrent.com/trials/histolog-comparison-to-standard-histology-32882https://curecurrent.com/trials/disitamab-vedotin-rc48-combined-with-penpulimab-ak105-for-neoadjuvant-treatment-of-her2-low-breast-cancer-32883https://curecurrent.com/trials/evaluation-of-somavac-100-sustained-vacuum-system-32884https://curecurrent.com/trials/ifact-incidental-findings-in-advanced-cancer-therapy-32885https://curecurrent.com/trials/developing-a-psychosexual-educational-partners-program-pepp-a-feasibility-study-32886https://curecurrent.com/trials/patient-reported-outcomes-after-oncoplastic-breast-conserving-surgery-32887https://curecurrent.com/trials/molecular-signature-for-breast-cancer-32888https://curecurrent.com/trials/a-study-to-characterize-colon-pathology-in-patients-with-her2-amplified-breast-cancer-treated-with-neratinib-32889https://curecurrent.com/trials/study-in-women-and-men-with-metastatic-breast-cancer-that-have-overexpression-of-erbb2-32890https://curecurrent.com/trials/nsaid-effects-on-clinical-and-imaging-breast-biomarkers-32891https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-sysa1901-vs-perjeta-of-her2-positive-breast-cancer-32892https://curecurrent.com/trials/effects-of-extracorporeal-shock-wave-therapy-added-to-complex-decongestivetherapy-in-pat-ent-with-lymphedeme-32893https://curecurrent.com/trials/impact-of-neo-adjuvant-therapy-associating-anthracyclines-and-taxanes-with-or-without-trastuzumab-on-skeletal-muscle-in-32894https://curecurrent.com/trials/clinical-histological-and-in-depth-molecular-characterization-as-well-as-experimental-models-of-liver-metastasis-from-pa-32895https://curecurrent.com/trials/telerehabilitation-in-survival-breast-cancer-patients-32896https://curecurrent.com/trials/the-ultrasound-guided-multiple-injection-costotransverse-block-for-mastectomy-and-primary-reconstructive-surgery-32897https://curecurrent.com/trials/exploratory-study-comparing-clearsight-system-2d-map-to-post-surgery-histopathological-analysis-in-lumpectomy-32898https://curecurrent.com/trials/efficacy-and-safety-of-oxybutynin-versus-paroxetine-in-aromatase-inhibitor-induced-vasomotor-symptoms-32899https://curecurrent.com/trials/a-study-of-tak-659-in-combination-with-nivolumab-in-participants-with-advanced-solid-tumors-32900https://curecurrent.com/trials/the-impact-of-pecs-blocks-on-postmastectomy-pain-syndrome-32901https://curecurrent.com/trials/qigong-for-ppsp-in-breast-cancer-pain-in-breast-cancer-survivors-32902https://curecurrent.com/trials/sapanisertib-in-combination-with-fulvestrant-in-women-with-advanced-or-metastatic-breast-cancer-after-aromatase-inhibito-32903https://curecurrent.com/trials/immunoassay-and-regulation-of-traditional-chinese-medicine-on-cancer-patients-32904https://curecurrent.com/trials/endometrial-changes-in-breast-cancer-women-32905https://curecurrent.com/trials/safety-and-efficacy-study-of-sapanisertib-in-combination-with-exemestane-or-fulvestrant-in-postmenopausal-women-with-est-32906https://curecurrent.com/trials/the-pioneer-01-study-of-the-imagio-breast-imaging-system-32907https://curecurrent.com/trials/a-first-in-human-study-of-cdk-002-exosting-in-subjects-with-advanced-metastatic-recurrent-injectable-solid-tumors-32908https://curecurrent.com/trials/phase-ii-trial-of-doxil-carboplatin-bevacizumab-in-triple-negative-untreated-metastatic-breast-cancer-32909https://curecurrent.com/trials/effects-of-kombucha-intervention-on-emotional-distress-and-sleep-quality-in-breast-cancer-survivors-32910https://curecurrent.com/trials/prevention-of-cardiovascular-diseases-caused-by-complex-treatment-of-patients-with-primary-operated-breast-cancer-32911https://curecurrent.com/trials/clinical-validation-of-radiomics-artificial-intelligence-application-to-breast-cancer-treatment-planning-32912https://curecurrent.com/trials/effect-of-precise-grip-strength-training-on-picc-catheter-related-thrombosis-in-cancer-patients-32913https://curecurrent.com/trials/lesion-composition-and-quantitative-imaging-analysis-on-breast-cancer-diagnosis-32914https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-safety-and-pharmacokinetics-of-giredestrant-plus-palbociclib-compared-with-anastrozole-32915https://curecurrent.com/trials/portable-scalp-cooling-system-for-the-improvement-of-chemotherapy-induced-hair-loss-in-patients-with-metastatic-breast-c-32916https://curecurrent.com/trials/predator-neoadjuvant-gene-prediction-for-breast-cancer-32917https://curecurrent.com/trials/precision-breast-conserving-surgery-with-guidance-32918https://curecurrent.com/trials/efficacy-of-capecitabine-with-adjuvant-radiotherapy-in-treatment-of-early-stages-breast-cancer-retrospective-study-32919https://curecurrent.com/trials/a-study-of-zn-c5-and-abemaciclib-in-participants-with-breast-cancer-32920https://curecurrent.com/trials/breast-cup-immobilization-device-ii-gcc-1047-32921https://curecurrent.com/trials/a-study-of-navicixizumab-monotherapy-or-in-combination-in-patients-with-select-advanced-solid-tumors-32922https://curecurrent.com/trials/the-influence-of-treatment-position-prone-vs-supine-on-whole-breast-target-32923https://curecurrent.com/trials/effect-of-physical-therapy-on-breast-cancer-related-lymphedema-32924https://curecurrent.com/trials/phase-2-study-of-pembrolizumab-carboplatin-in-breast-related-cancer-antigens-related-metastatic-breast-cancer-pembraca-32925https://curecurrent.com/trials/diffusion-weighted-magnetic-resonance-imaging-of-the-breast-during-chemotherapy-response-evaluation-32926https://curecurrent.com/trials/epcam-and-p53-expressions-in-infiltrating-duct-carcinoma-of-the-breast-32927https://curecurrent.com/trials/a-study-of-efficacy-and-safety-of-lag525-in-combination-with-spartalizumab-or-with-spartalizumab-and-carboplatin-or-with-32928https://curecurrent.com/trials/oncologic-safety-of-sentinel-lymph-node-biopsy-in-clinically-palpable-axillary-lymph-node-in-breast-cancer-patients-32929https://curecurrent.com/trials/acceptability-of-active-monitoring-am-as-a-treatment-option-for-ductal-carcinoma-in-situ-dcis-32930https://curecurrent.com/trials/cohort-study-of-prospective-validation-of-predictive-factors-and-biological-imaging-of-response-to-bevacizumab-and-pacli-32931https://curecurrent.com/trials/a-dose-escalation-study-evaluating-the-combination-of-trastuzumab-emtansine-t-dm1-with-neratinib-in-women-with-metastati-32932https://curecurrent.com/trials/mri-parenchymal-enhancement-a-new-marker-of-breast-cancer-risk-32933https://curecurrent.com/trials/thero2-01s22-in-her2-positive-breast-cancer-32934https://curecurrent.com/trials/prognostic-value-of-some-biochemical-markers-in-breast-cancer-32935https://curecurrent.com/trials/pectoral-nerve-block-during-mastectomy-32936https://curecurrent.com/trials/a-pharmacokinetic-study-comparing-eg1206a-and-perjeta-pertzumab-in-healthy-male-volunteers-32937https://curecurrent.com/trials/basket-trial-for-combination-therapy-with-durvalumab-anti-pdl1-medi4736-and-tremelimumab-anti-ctla4-in-patients-with-met-32938https://curecurrent.com/trials/autotaxin-a-potential-biomarker-for-breast-cancer-32939https://curecurrent.com/trials/carbon-fibre-accessory-cara-for-supine-breast-positioning-to-reduce-toxicity-in-whole-breast-radiotherapy-32940https://curecurrent.com/trials/efficacy-of-iort-with-ct-guided-hdr-brachytherapy-for-treatment-of-breast-cancer-32941https://curecurrent.com/trials/identification-of-novel-genetic-factors-that-contribute-to-risk-for-breast-cancer-32942https://curecurrent.com/trials/effects-of-active-release-technique-art-on-pectoralis-minor-tightness-in-post-mastectomy-women-32943https://curecurrent.com/trials/talimogene-laherparepvec-in-treating-patients-with-recurrent-breast-cancer-that-cannot-be-removed-by-surgery-32944https://curecurrent.com/trials/contrast-ultrasound-detection-of-sentinel-lymph-nodes-32945https://curecurrent.com/trials/chloroquine-with-taxane-chemotherapy-for-advanced-or-metastatic-breast-cancer-after-anthracycline-failure-cat-32946https://curecurrent.com/trials/a-dose-escalation-study-of-proton-and-carbon-ion-irradiation-for-her2-positive-and-triple-negative-breast-cancer-32947https://curecurrent.com/trials/mayo-designed-soft-tissue-ultrasound-detectable-marker-32948https://curecurrent.com/trials/efficacy-and-safety-study-of-eg12014-compared-with-herceptin-in-subjects-with-her2-positive-early-breast-cancer-32949https://curecurrent.com/trials/a-prospective-phase-ii-study-for-adjuvant-hypofractionated-intensity-modulated-proton-radiotherapy-for-post-operative-br-32950https://curecurrent.com/trials/real-world-data-on-clinical-characteristics-demographics-and-outcomes-of-patients-with-metastatic-breast-cancer-in-turke-32951https://curecurrent.com/trials/pectoralis-nerve-block-and-quality-of-recovery-in-mastectomy-patients-32952https://curecurrent.com/trials/ultrasound-enhanced-delivery-of-chemotherapy-to-patients-with-liver-metastasis-from-breast-and-colorectal-cancer-32953https://curecurrent.com/trials/ribociclib-and-endocrine-therapy-or-chemotherapy-with-or-without-bevacizumab-for-metastatic-breast-cancer-in-first-line-32954https://curecurrent.com/trials/anti-pd-1-antibody-with-radiation-therapy-in-patients-with-her2-negative-metastatic-breast-cancer-32955https://curecurrent.com/trials/metabolomic-profiling-of-erector-spinae-plane-block-for-breast-cancer-surgery-32956https://curecurrent.com/trials/dose-escalation-study-to-assess-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-qbs10072s-32957https://curecurrent.com/trials/a-pilot-study-of-ultrasound-guided-vacuum-assisted-excision-of-breast-cancers-32958https://curecurrent.com/trials/investigating-safety-tolerability-and-efficacy-of-azd5363-when-combined-with-paclitaxel-in-breast-cancer-patients-32959https://curecurrent.com/trials/a-study-evaluating-ft-sw-in-unilateral-breast-cancer-related-lymphedema-patients-32960https://curecurrent.com/trials/the-effect-of-octreotide-on-wound-drainage-after-mastectomy-32961https://curecurrent.com/trials/calorie-restriction-with-or-without-metformin-in-triple-negative-breast-cancer-32962https://curecurrent.com/trials/pyrotinib-combined-with-brain-radiotherapy-in-breast-cancer-patients-with-brain-metastases-32963https://curecurrent.com/trials/pioneer-study-of-lifestyle-intervention-to-reduced-breast-cancer-risk-32964https://curecurrent.com/trials/effect-of-nurse-led-supportive-care-on-caregiver-burden-and-well-being-32965https://curecurrent.com/trials/prelude-study-of-lymphatic-surgery-to-treat-breast-cancer-related-lymphoedema-32966https://curecurrent.com/trials/single-arm-open-label-clinical-study-of-sz011-in-the-treatment-of-advanced-triple-negative-breast-cancer-32967https://curecurrent.com/trials/monitoring-and-predicting-chemotherapy-response-using-dosi-32968https://curecurrent.com/trials/scout-reflector-for-tagging-lymph-nodes-for-targeted-removal-in-patients-with-breast-cancer-32969https://curecurrent.com/trials/to-study-clinical-effectiveness-and-safety-of-olaparib-monotherapy-in-metastatic-breast-cancer-patients-32970https://curecurrent.com/trials/adjuvant-ovarian-suppression-plus-aromatase-inhibitor-or-tamoxifen-in-young-women-32971https://curecurrent.com/trials/effect-of-physical-exercise-on-tumor-proliferation-of-luminal-b-breast-cancer-patients-32972https://curecurrent.com/trials/remediation-for-mild-cognitive-deficits-after-cancer-32973https://curecurrent.com/trials/unraveling-kadcyla-resistance-in-human-epidermal-growth-factor-receptor-2-her2-positive-advanced-breast-cancer-katia-32974https://curecurrent.com/trials/the-effect-of-reiki-on-symptom-control-and-quality-of-life-in-breast-cancer-patients-32975https://curecurrent.com/trials/comparison-of-recovery-from-general-anesthesia-in-remimazolam-with-flumazenil-vs-propofol-32976https://curecurrent.com/trials/a-phase-ii-study-evaluating-the-efficacy-and-safety-of-pembrolizumab-in-combination-with-chemotherapy-as-neoadjuvant-the-32977https://curecurrent.com/trials/study-to-assess-the-effect-of-co-administration-of-azd9833-on-the-pharmacokinetics-of-midazolam-of-omeprazole-of-celecox-32978https://curecurrent.com/trials/spy-x-a-study-to-assess-the-feasibility-of-using-spy-alone-for-sentinel-node-localization-for-melanoma-or-breast-cancer-32979https://curecurrent.com/trials/the-study-of-quadruple-therapy-quercetin-zinc-metformin-and-egcg-as-adjuvant-therapy-for-early-metastatic-breast-cancer-32980https://curecurrent.com/trials/prospective-research-for-elderly-65-years-old-early-breast-cancer-patients-32981https://curecurrent.com/trials/a-study-of-pdr001-in-combination-with-lcl161-everolimus-or-panobinostat-32982https://curecurrent.com/trials/an-observational-study-of-kadcyla-safety-in-breast-cancer-32983https://curecurrent.com/trials/feasibility-of-a-remotely-delivered-yoga-intervention-on-cognitive-function-in-breast-cancer-survivors-32984https://curecurrent.com/trials/bexarotene-in-preventing-breast-cancer-in-patients-at-high-risk-for-breast-cancer-32985https://curecurrent.com/trials/high-risk-breast-duct-epithelium-32986https://curecurrent.com/trials/what-are-the-benefits-and-harms-of-risk-stratified-screening-in-the-nhs-breast-screening-programme-study-protocol-32987https://curecurrent.com/trials/pk-and-drug-interaction-study-of-utidelone-plus-capecitabine-in-patients-with-advanced-breast-cancer-32988https://curecurrent.com/trials/evaluation-of-targeted-axillary-lymph-node-dissection-in-node-positive-breast-cancer-patients-post-neo-adjuvant-therapy-32989https://curecurrent.com/trials/a-study-of-bevacizumab-avastin-in-combination-with-neoadjuvant-treatment-regimens-in-participants-with-primary-human-epi-32990https://curecurrent.com/trials/a-study-to-assess-the-pharmacokinetics-of-camizestrant-azd9833-when-administered-alone-and-in-combination-with-itraconaz-32991https://curecurrent.com/trials/association-between-her2-status-and-pcr-rate-in-er-positive-breast-cancer-receiving-neoadjuvant-endocrine-or-chemotherap-32992https://curecurrent.com/trials/cryoablation-atezolizumab-nab-paclitaxel-for-locally-advanced-or-metastatic-triple-negative-breast-cancer-32993https://curecurrent.com/trials/acupuncture-in-chemotherapy-induced-peripheral-neuropathy-in-women-with-breast-cancer-32994https://curecurrent.com/trials/open-label-dose-escalation-study-of-pemigatinib-in-subjects-with-advanced-malignancies-fight-101-32995https://curecurrent.com/trials/cesm-abmr-breast-cancer-screening-trial-32996https://curecurrent.com/trials/carbon-dioxide-fractional-laser-in-treating-participants-with-stage-0-iii-hormone-receptor-positive-breast-cancer-with-v-32997https://curecurrent.com/trials/feasibility-study-of-intraoperative-imaging-in-breast-cancer-32998https://curecurrent.com/trials/ginseng-in-decreasing-cancer-related-fatigue-after-treatment-in-cancer-survivors-32999https://curecurrent.com/trials/enhancing-shared-decision-making-in-breast-cancer-33000